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ABSTRACT 
 
 
CD82, a tetraspanin, is a tumor metastasis suppressor. Tetraspanins are membrane 
spanning proteins that play critical roles in diverse biological and pathological processes, 
e.g., the regulation of cancer metastasis. CD82 is ubiquitously expressed in various types 
of tissues, but its expression becomes down-regulated or lost in a majority of metastatic 
tumors.  It inhibits tumor metastasis without affecting primary tumor growth. Cancer 
patients whose tumors contain CD82 exhibit minimal metastasis. We know that CD82 
functions as a tumor metastasis suppressor but the mechanism by which this occurs is 
largely unknown. CD82 can be found on the plasma membrane as well as in intracellular 
compartments, and CD82 undergoes endocytosis. The intracellular trafficking of proteins 
plays a key role in their functions. The mechanism by which CD82 is able to traffic 
remains not well know. Notably, CD82 contains an YXXΦ internalization and 
intracellular trafficking motif in its C-terminal cytoplasmic domain. Previous reports 
suggest that the mutation of the YXXΦ motif of a tetraspanin will disrupt internalization 
and subsequent trafficking. We have established the stable transfectant of CD82 YVAA 
mutant, which contains a mutation in the YXXΦ motif of CD82.  
 
This research focuses on the roles of CD82’s YXXΦ motif 1) in intracellular 
trafficking of CD82 and its associated proteins as well as 2) in the CD82-mediated 
inhibition of the migration of metastatic tumor cells. Results from the internalization 
assays reveal that the YXXΦ motif is not required for the internalization of CD82, nor 
does the mutation of this motif have drastic effect on the steady state distribution of 
CD82. Results from the intracellular trafficking and recycling assays reveal that there is a 
defect in the intracellular trafficking of CD82 upon the mutation of its YXXФ motif. We 
found that both CD82 WT and CD82 YVAA mutant trafficked to the late 
endosomes/lysosomal compartments. We also observed that the recycling of CD82 
proteins is Rab 11-mediated process and that the mutation of the YXXΦ motif 
significantly decreases the CD82 YVAA release via exosomes.  Our study also revealed 
that the CD82 YVAA mutant traffics to and accumulates within the lysosomal 
compartments within the cells. Regarding the role of CD82 trafficking in cell movement, 
we found that that the mutation of CD82 YXXΦ  motif results in a loss of function in 
CD82-mediated inhibition of collective cell migration and cell invasion but appears not to 
affect CD82-mediated inhibition of solitary cell migration. In addition, CD82 YVAA 
mutation increases cell-cell adhesion in a calcium dependent manner, which likely results 
from altered trafficking of cell-cell adhesion proteins.  
 
From the results obtained in this study, we conclude that the YXXΦ motif of 
CD82 is not essential for CD82 internalization but rather regulates CD82 trafficking to 
the late endosome where CD82 is recycled back to the plasma membrane or secreted into 
the extracellular environment via exosomes. CD82 trafficking also regulates the 
trafficking and function of cell adhesion proteins. Furthermore, the proper trafficking and 
recycling of CD82 plays a key role in maintaining its motility suppressive function.  
Further studies will determine 1) the molecular mechanism by which CD82 trafficking 
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regulates the behavior of cell adhesion proteins and 2) the effect of aberrant CD82 
trafficking on tumor metastasis in animal models.   
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1 
CHAPTER 1.    INTRODUCTION 
 
 
1.1 INTRACELLULAR TRAFFICKING 
 
Endocytosis is the mechanism by which cells uptake their nutrients and solutes 
from the surrounding environment. The process of endocytosis is used by all cells of the 
body and regulates numerous biological processes such as regulation of cell surface 
receptors, maintaining the homeostasis of cellular cholesterol, antigen presentation, and 
maintenance of cellular processes (Xu et al 2009). Endocytosis can be classified into two 
major categories: phagocytosis and pinocytosis.  
 
Phagocytosis is the process by which cells bind and internalize particulate matter 
larger than around 0.75 µm in diameter, such as small-sized dust particles, cell debris, 
micro-organisms and even apoptotic cells, which only occurs in specialized cells (Conner 
and Schmid 2003; Soldati and Schliwa 2006; Xu et al 2009). 
 
Pinocytosis is a “cell drinking’ process that uptakes small particles and solutes 
(Conner and Schmid 2003; Soldati and Schliwa 2006). Pinocytosis can further be 
subdivided into 4 subclasses, clathrin-mediated endocytosis, caveolae-mediated 
endocytosis, macropinocytosis, and clathrin and caveolae independent endocytosis 
(Alberts et al 2002; Conner and Schmid 2003).   
 
Clathrin-mediated endocytosis is mediated by the small vesicles that are 
approximately 100 nm in diameter and a morphologically characteristic crystalline coat 
made up of a complex of cytosolic proteins, clathrin and its associated proteins. These 
small vesicles are called clathrin-coated vesicles (CCVs) and are found in virtually all 
cells. Before CCVs are formed, clathrins and their associated proteins cluster at the 
plasma membrane to form membrane microdomains and cause the local invagination of 
the plasma membrane termed clathrin-coated pits. The clathrin-coated pits can 
concentrate the large extracellular molecule ligands, which bind their transmembrane 
receptors  to trigger the clathrin-mediated endocytosis of these ligands. These 
extracellular ligands include low-density lipoprotein, transferrin, growth factors, and 
antibodies. 
 
Caveolae are the most commonly reported non-clathrin-coated plasma membrane 
buds, which exist on the cell surface of many, but not all, cell types. They consist of the 
cholesterol-binding protein caveolin (Vip21). Caveolin is localized in the lipid bilayer 
and is enriched in cholesterol and glycolipids. Caveolae are small, approximately 50 nm 
in diameter, flask-shape pits in the plasma membrane that resemble the shape of caves, 
hence termed as caveolae (Conner and Schmid 2003). They can constitute up to one third 
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of the plasma membrane of the cells in some tissues, being especially abundant in smooth 
muscle, type I pneumocytes, fibroblasts, adipocytes, and endothelial cells. The uptake of 
extracellular molecules such as albumin is believed to be mediated via caveolae. 
 
Macropinocytosis usually occurs at highly ruffled regions of the plasma 
membrane (Conner and Schmid 2003). Macropinocytosis starts from the invagination of 
the local plasma membrane to form a pocket, which then pinches off into the cell to form 
a relatively large vesicle, 0.5–5 µm in diameter, filled with a large volume of 
extracellular fluid and soluble molecules, equivalent to ~100 CCVs in volume. The filling 
of the pocket occurs in a non-specific manner. The macropinocytic vesicle then travels 
into the cytosol and fuses with other intracellular vesicles such as endosomes and 
lysosomes. 
 
The clathrin- and caveola-independent endocytosis involves a group of poorly 
defined mechanisms. Some clathrin- and caveola-independent endocytosis appears to use 
lipid rafts or lipid raft-like domains as the membrane platform to initiate endocytosis. 
Lipid rafts are small cholesterol rich microdomains that freely diffuse on the cell surface 
(Conner and Schmid 2003). Their unique lipid composition provides a physical basis for 
specific sorting of membrane proteins and/or glycolipids based on their transmembrane 
regions (Conner and Schmid 2003). An earlier study from our lab revealed that 
tetraspanin CD82 undergoes clathrin- and caveola-independent endocytosis, lipid raft 
mediated endocytosis (Xu et al 2009). 
 
 
1.2 REGULATION OF INTRACELLULAR TRAFFICKING 
 
Proteins are endocytosed by several different mechanisms. Once across the 
plasma membrane, the proteins are sorted/targeted to different organelles within the cell 
(Bonifacino and Traub 2003; Conner and Schmid 2003; Escola et al 1998; Gruenberg 
2001; Kang and Creswell 2002; Kerkhof et al 2001; Lakkaraju and Boulan-Rodriguez 
2008; Lodish et al 2004; Mukherjee et al 1997; Savina et al 2003; Traub 2003;   
Wessling-Resnick and Braell, 1990). One of the deciding factors in the protein’s destiny 
is the type of sorting motif that they contain (Lakkaraju and Boulan-Rodriguez 2008).  
 
The most studied sorting motifs are the delucine based and tyrosine based sorting 
motifs (Brown and Brenton 2000). Both of these sorting motifs are found within the 
cytoplasmic tails of numerous proteins and are important regulators of intracellular 
trafficking and sorting (Brown and Brenton 2000). The delucine based sorting motif has 
been show to regulate protein trafficking to the trans-golgi network, to the lysosomes and 
is important for the internalization of numerous proteins (Bonfacino and Traub 2003).   
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Tyrosine-based sorting motif, YXXΦ, mediates the targeting of many integral 
membrane proteins of the secretory pathway. Within the YXXΦ amino acid sequence, the 
Y represents the tyrosine residue and studies have shown that the tyrosine residue is 
responsibe for the function of the motif (Bonfacino and Traub 2003; Marks et al 1997). 
These studies revealed that mutation or replacement of the tyrosine residue with any 
other residue led to a defect in the recognition of the motif (Bonfacino and Traub 2003). 
The Φ residue represents a bulky hydrophobic residue and can be substituted with any of 
the hydrophobic amino acids without a functional consequence (Bonfacino and Traub 
2003; Marks et al 1997; Renard et al 2010). The X residue can be substituted with any of 
the amino acids.  
 
Transmembrane proteins, such as tetraspanins contain the tyrosine based sorting 
motif, YXXФ (Bonifacino and Traub 2003; Kang and Cresswell 2002; Tonoli and Barrett 
2005). In fact, 13 out of the 33 tetraspanin superfamily members contain the YXXΦ 
motif (Berditchevski et al 2007). This motif plays a role in the 1) rapid internalization of 
the protein from the plasma membrane, and/or 2) targeting them to the endosomes and 
lysosomes (Berditchevsky and Odintsina 2007; Bonifacino and Traub 2003).  
 
The transmembrane proteins that contain the YXXФ motif use the clathrin-coated 
pit as their mode of endocytosis (Conner and Schmid 2003; Traub 2003). The proteins 
using clathrin-coated pits interact with AP2 complexes, mainly μ2 subunit, through their 
tyrosine-based sorting motifs (Conner and Schmid 2003; Traub 2003).  
 
Earlier studies demonstrated that the mutations of the Y or the Ф residues of this 
motif abolishes the endocytosis and subsequent the trafficking of the transmembrane 
proteins that carry this motif (Bonifacino and Traub 2003; Guarnier 1993; Liu et al 2007; 
Murkherjee et al 1997). Tetraspanins are a superfamily of type III transmembrane 
proteins that span the membrane four times. Some tetraspanins such as CD9, CD63, 
CD82, and CD151 contain the YXXФ trafficking motif in the C-terminal cytoplasmic 
domains. In order to shed light on the trafficking mechanism of tetraspanins, the YXXФ 
motifs of CD63 and CD151 have been mutated (Liu et al 2007; Rous et al 2002). In NIH 
3T3 cells, mutation of the YXXФ motif of CD151 led to the abrogation of CD151 
internalization and subsequent trafficking (Liu et al 2007). Similar results were observed 
in normal rat kidney cells upon mutation of CD63 (Rous et al 2002). Also, another body 
of evidence comes from reports that patients with familial hypercholesterolemia, 
containing a mutation in the YXXФ motif of the low density lipid protein (LDL) 
receptor, exhibit a defect in the internalization of LDL (Mukherjee et al 1997).  
Tetraspanin CD82, which contains the YXXФ motif in the C-terminal domain, is 
localized at the plasma membrane as well as in intracellular vesicles (Liu and Zhang 
2006; Miranti 2008).  Although an earlier study from our lab demonstrated that the 
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endocytosis of CD82 is independent of clathrin-mediated endocytosis, there have not 
been any reports which have addressed the function of the YXXΦ motif of CD82.   
 
 
1.2.1 The endosomal and lysosomal trafficking 
 
Another deciding factor for the intracellular trafficking of proteins is which Rab 
GTPase proteins the proteins will encounter. Rab proteins are a family of ubiquitously 
expressed proteins that are essential for directing the various steps of intracellular 
trafficking .Once the protein is internalized, it is delivered to the endosomes, with the aid 
of Rab 5 (Kerkhof et al 2001; Lakkaraju and Boulan-Rodriguez 2008; Pols and 
Klumperman 2008). The endosomes are divided into the following categories: early, late, 
or recycling endosomes. The early endosomes are responsible for directing internalized 
proteins to their final fates, either being recycled or degraded. Proteins that leave the 
early endosomes and go to the late endosomes are usually sorted to the lysosome for 
degradation (Kerkhof et al 2001; Wessling-Resnick and Braell 1990). Those that leave 
the early endosomes and report to the recycling endosomes are recycled back to the 
plasma membrane (Bonifacino and Traub 2003; Lakkaraju and Boulan-Rodriguez 1990; 
Mukherjee et al 1997). 
 
Some late endosomes accumulate internalized vesicles within their lumen and 
ultimately mature into the multivesicular bodies (MVBs), a form of late endosomes 
(Delcayre et al 2005; Duijvesz et al 2011; Escola et al 1998; Palanisamy et al 2010; Pols 
and Klumperman 2008; Savina et al 2003; Simpson et al 2008; Stoorvogel 2002). Once 
proteins reach the late endosome/multivesicular bodies, they have two fates: either being 
sorted to the lysosome for degradation or being secreted into the extracellular space after 
the MVBs fuses with the plasma membrane (Stoorvogel et al 2002). An example of 
proteins targeted for lysosomal degradation is growth factor receptors such as epidermal 
growth factor receptors, EGFR, and the lysosomal targeting thereby shuts down its 
signaling processes (Felder et al 1990).    
 
The sorting of proteins into MVBs is a highly regulated process and has been 
shown to involve ubiquitination (Record et al 2011). Generally the proteins targeted for 
degradation are tagged with ubiquitin, termed ubiquitination, and trafficked to the 
multivesicular bodies for further lysosomal targeting and degradation (Alberts et al 2002; 
Hislop and von Zastrow 2011; Marsh and van Meer 2008). The trafficking of      
ubiquitin-tagged proteins to MVBs uses either an endosomal sorting complex required 
for transport (ESCRT), dependent or independent mechanism.  
 
An important regulator for protein sorting and multivesicular body formation is 
ESCRT (Record et al 2011). During intracellular trafficking, the ESCRT machinery is 
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recruited to the cytosolic side of the endosomal membrane thus allowing the proper 
sorting of selected proteins to the interluminal vesicles, which ultimately leads to the 
formation of the MVBs (Katzmann et al 2002; Record et al 2011). The ESCRT 
machinery is composed of three protein complexes, ESCRT-I, ESCORT-II, and   
ESCRT-III (Record et al 2011). The Vps27/Hrs complex recruits Tsg101, an ESCRT-1 
complex member. Tsg101 binds the ubiquitinated proteins and activates the ESCRT-II 
complex. Tsg101 further recruits the ESCRT-III complex via ESCRT II and Alix (Record 
et al 2011). The ESCRT-III complex concentrates and plays a role in the formation of the 
multivesicular bodies by  recruiting an enzyme that removes the ubiquitin tag from the 
protein prior to the protein being sorted into the multivesicular bodies (Février and 
Raposo 2004; Record et al 2011). It has also been shown that knock-down of Hrs and 
Tsg101 resulted in reduced trafficking of EGF to the interluminal vesicles, ILVs, of the 
MVBs (Trajkovic et al 2008).  
 
For the ESCRT-independent sorting mechanism, the ubiquitinated protein is 
incorporated into detergent-resistant complexes, as in the case for MHC class II proteins. 
In immature dendritic cells, the sorting of MHC class II proteins to the MVBs is largely 
dependent upon the interaction of dendritic cells with cognate T cells. The resulting 
interaction is that ubiquitination is blocked and the MHC class II proteins are sorted 
together with the tetraspanin CD9 into MVBs (Buschow et al 2009). The tetraspanin 
superfamily of proteins, highly enriched in exosomes, has a high affinity for cholesterol 
and sphingolipids such as ceramide, a precursor for exosome release which potentially 
may create domains destined for the MVBs (de Gassat et al 2003). For example, in     
Oli-neu cells the proteolipid protein PLP is segregated into distinct subdomains and are 
transferred to exosomes in a raft-based, ceramide-dependent, and ESCRT-independent 
pathway (Record et al 2011; Trajkovic et al 2008). Tetraspanins also associates with and 
sequesters other cell surface proteins into membrane complexes at the plasma membrane 
such as other tetraspanins, integrin, and growth factor receptors. The                       
ESCRT-independent sorting of MHC class II proteins provides a putative avenue for the 
MVB trafficking and exosomal secretion of other transmembrane proteins. Other protein-
protein interactions with the Alix and heat-shock proteins HSP 70 and HSC 70 allow 
proteins to traffic to the exosomes (Record et al 2011).   
 
 
1.2.2 The formation and release of exosomes 
 
It is noteworthy to mention that not all proteins destined for late endosomes are to 
be degraded, some of the late endosomes, especially MVBs, fuse with the plasma 
membrane and release their contents in the form of small vesicles, deemed exosomes, to 
the extracellular environment (Escola et al 1998; Pols and Klumperman 2008; Savina et 
al 2003). Exosomes are the nano-sized vesicles that were identified during the study of 
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reticulocyte maturation (Harding et al 1983; Pan and Johnstone 1983). Since then, 
exosomes have been detected to be secreted from nearly all cells types including 
dendritic cells, macrophages, lymphocytes, salivary gland epithelial cells, and cancer 
cells (Delcayre et al 2005; Duijvesz et al 2011; Escola et al 1998; Heijene et al 1999; 
Palanisamy et al 2010; Pols and Klumperman 2008; Savina et al 2003; Simpson et al 
2008; Stoorvogel 2002). Exosomes are also detected in bodily fluid such as saliva, 
plasma, urine, breast milk, amniotic fluid, synovial fluid, and bronchoaveolar lavage fluid 
(Record et al 2011). 
 
Exosome biogenesis initially stems from endocytosis and is largely regulated by 
the formation of MVBs (Delcayre et al 2005; Duijvesz et al 2011; Escola et a l 1998; 
Heijene et al 1999; Palanisamy et al 2010; Pols and Klumperman 2008; Savina et al 
2003; Simpson et al 2008; Stoorvogel 2002), as discussed above.   
  
The secretion of exosomes is regulated by a different set of molecules. To date the 
major regulator of exosome secretion is the Rab GTPase family of proteins. Exosome 
secretion has been shown to be regulated by Rab27a and Rab27b (Ostrowski et al 2010; 
Pfeffer 2010). It was determined that the knock-down of Rab27a and Rab27b decreased 
exosome secretion without effecting exosome composition (Ostrowski et al 2010). In 
addition, Savina et al reported that Rab 11 also plays a role in the exosome pathway 
(Savina et al 2003). Moreover, exosome secretion is also regulated by the lipid ceramide 
(Trajkovic et al 2008).  Ceramide is generated by the hydrolysis of the phosphocholine 
moiety of sphingomyelin (SM) by sphingomyelinases (Smases) (Trajkovic et al 2008). 
Inhibition of ceramide by the treatment with a sphingomyelinase (nSMase) inhibitor 
GW4869 in Oli-neu cells led to a decrease in exosome secretion (Trajkovic et al 2008). It 
was also observed that treatment with an exogenous sphingomyelinase or ceramide led to 
an increase in the production and release of exosomes in the Oli-neu cells (Trajkovic et al 
2008). 
 
Not surprising, exosomes and MVBs have similar molecular compositions 
(Duijvesz et al 2011; Record et al 2011; Stoorvogel et al 2002; Trajkovic et al 2008).  
There are many common proteins found in exosomes and MVBs, however the overall 
composition of exosomes depends largely on the cells from which they originate (Record 
et al 2011; Stoorvogel et al 2008). Common proteins found within exosomes are Alix, 
flotillin-1, heat shock proteins such as Hsp70, Hsp90, and Hsc 70, LBPA, lipids such as 
ceramide, tetraspanins such as CD9, CD63, CD81, CD82, GPI-anchored proteins such as 
TNFR-1, antigen presenting molecules MHC-I and MHC-II, cell adhesion molecules 
such as integrins, cadherins, and I-CAM, luminal proteins such as annexin 2 and 
cytokines, ESCRT machinery proteins such as Tsg101, Alix, and Hrs, and the proteins 
involved in transcription, protein synthesis, trafficking, and signaling such as histones, 
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ribosomal proteins, ubiquitin, ARF and Rab GTPase  family members, G proteins, RhoA, 
and kinases (Duijvesz et al 2011; Record et al 2011; Théry et al 1999; Théry et al 2001). 
Exosomes also contain non-protein materials such as mRNA and microRNAs (miRNA) 
(Duijvesz et al 2011; Mathivanan and Simpson 2009; Record et al 2011; Théry et al 
2001; Valadi et al 2007). In fact, there are at least 2400 proteins, 900 mRNA, and 275 
miRNA found in exosomes to date (Mathivanan and Simpson 2009).     
 
 
1.3 CELL-CELL ADHESION 
 
Cell-cell adhesions are the characteristic of multi-cellular organisms (Alberts et al 
2002). Cell-cell adhesion plays crucial roles in a wide range of physiological and 
pathological functions ranging from sperm-egg fusion, organogenesis, tissue stability, 
inflammation, leukocyte rolling, collective cell movement, and tumor metastasis. In 
collective cell migration, a cohort of cells form cell-cell contact with each other and 
move together. In this process, cell-cell adhesion coordinates the behavior of individual 
cells and connects them into a migratory unit. 
 
Cell-cell adhesion can be classified into calcium-dependent and                 
calcium-independent cell-cell adhesion events based on the requirement of bivalent 
cation calcium in the formation of cell-cell contacts (Lodish et al 2004). The membrane 
proteins responsible for calcium-dependent cell-cell adhesion include cadherins and 
selectins, while the proteins such as immunoglobulin superfamily (IgSF) proteins are 
responsible for calcium-independent cell-cell adhesion (Lodish et al 2004).   
 
Cadherins are the major cell-cell adhesion proteins (CAMs) responsible for Ca2+ 
dependent cell-cell adhesion in vertebrate tissues and are expressed on virtually all cell 
types. Cadherins are single-pass transmembrane glycoproteins, and each cadherin 
contains approximately 100-750 amino acids. Cadherins associate with each other in the 
plasma membrane to form dimers or oligomers. The large extracellular part of the 
polypeptide chain is usually folded into five or six cadherin repeats and have calcium 
ions positioned between each pair of repeats. This cadherin-calcium orientation creates a 
stiff and rigid structure resulting in stronger cell-cell adhesions.  In cell culture, the 
removal of extracellular Ca2+ or treatment with anti-cadherin antibody disrupts cell-cell 
adhesion, and the protein is rapidly degraded by proteolytic enzymes (Lodish et al 2004). 
 
Most cadherins are normally concentrated in adherens junctions, which are 
connected to cortical actin cytoskeletons of the cells and hold cells together in a 
homotypic cell-cell adhesion manner.  Some cadherins such as desmoglein and 
desmocollin form desmosomes, which are connected to the intermediate filament 
cytoskeleton and often found in epithelial tissues (Lodish et al 2004). Cadherins can be 
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grouped into classical and non-classical cadherins. There are four major classical 
cadherins: E-cadherins, which are highly expressed in various epithelial tissues;           
VE-cadherins, which are limited in endothelial tissues; N-cadherins, which are abundant 
in nerve, muscle, lens, as well as fibroblasts; and P-cadherins, which are present in 
placenta and epidermis (Lodish et al 2004). The nonclassical cadherins include 
desmosomal cadherins such as desmoglein and desmocollin, protocadherins, and atypical 
cadherins (Lodish et al 2004).   
 
Selectins are another family of cell-cell adhesion molecules and contain       
single-chain transmembrane glycoproteins that mediate numerous Ca2+ dependent     
cell-cell interactions found within the blood stream. Selectins play a very important role, 
with the aid of integrins, in the binding of white blood cell to endothelial cells during 
inflammation (Lodish et al 2004). 
 
The immunoglobulin superfamily (IgSF) of proteins is a large group of cell 
surface and soluble proteins that are involved in the recognition, binding, or adhesion 
processes of cells. Members of the IgSF are characterized based upon shared       
immunoglobulin domains or folds (Lodish et al 2004). Members of the IgSF include cell 
surface antigen receptors, co-receptors, and co-stimulatory molecules of the immune 
system, molecules involved in antigen presentation to lymphocytes, cell adhesion 
molecules, certain cytokine receptors and intracellular muscle proteins. For cell-cell 
adhesion, IgSF proteins such as N-CAM mediate homotypic cell-cell adhesion, while 
IgSF proteins such as ICAM and VCAM engage heterotypic cell-cell adhesion (Lodish et 
2004).  
 
Cell-to-cell adhesion can form the cell junctional structures that can be visualized 
under electron microscope. These junctional structures include adherence junction, 
desmosome, tight junction, and gap junction. Cadherins are the cell-cell adhesion 
transmembrane proteins that determine the formation of adherence junction and 
desmosome in a calcium-dependent manner. Cadherins also plays key roles in regulating 
collective cell movement and tumor metastasis (Canal et al 2010; Serrels et al 2009). For 
example, E-cadherin is a well accepted tumor metastasis suppressor (Berx et al 1998; 
Birchmeier and Behrens 1994; Jeanes et al 2008; Perrais et al 2007; Serrels et al 2009; 
Thiery et al 2002). 
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1.4 TETRASPANINS AND TETRASPANIN-ENRICHED MICRODOMAINS 
(TEMS) 
 
 
1.4.1 Tetraspanins 
 
Tetraspanins are a superfamily of transmembrane proteins containing 4 
membrane-spanning segments. Tetraspanin proteins regulate cell morphology, cell 
adhesion, cell motility, cell fusion, and signaling in various organs and tissues such as 
brain, immune system, and cardiovascular system under physiological conditions 
(Berditchevski 2001; Helmer 2003; Miranti 2008; Pols 2008; Sridhar 2006). Tetraspanins 
also regulate these cellular and molecular events during pathological conditions such as 
tumors, viral infection, and inflammation.  
 
To qualify for membership in the tetraspanin superfamily, a protein must have 
four transmembrane domains and several conserved amino acids, including an absolutely 
conserved CCG motif and two other cysteine residues that contribute to two crucial 
disulphide bonds within the second extracellular loop (Berditchevski 2007; Liu and 
Zhang 2006; Miranti 2009; Richardson 2011; Tonoli 2005; Yang et al 2001; Yunta 
2003). Of the 200–350 amino acids that are found in tetraspanins, 13–31 of them reside 
in the short extracellular loop (EC1), for which the structural information is not yet 
available. The large extracellular loop (EC2, 69–132 amino acids) is subdivided into a 
constant region and a variable region, which contains nearly all of the known        
protein-protein interaction sites in tetraspanins. The first, third and fourth transmembrane 
domains often contain polar residues, which play important roles in 1) maintaining the 
structural stability of tetraspanins and 2) interacting with other tetraspanins and 
transmembrane proteins (Bari et al 2009). Almost all tetraspanins are modified by the 
post-translational addition of palmitate to membrane-proximal cysteine residues. In fact, 
of the 33 mammalian family members, 30 contain at least one and as many as seven 
membrane-proximal palmitoylation sites. Tetraspanin proteins also undergo                   
N-glycosylation within its large extracellular loop. 
 
 
1.4.2 Tetraspanin-enriched microdomain 
 
Tetraspanins tend to associate with each other to form homodimers and 
heterodimers. On the bases of these dimers, tetraspanins further associate to assemble 
into multimeric transmembrane complex (Berditchevski 2007; Pols 2008; Richardson 
2011; Yunta 2003; Zhou et al 2004). For example, tetraspanin CD82 associates with 
tetraspanins CD9, CD81, CD63, and CD151 (Liu and Zhang 2006; Miranti 2009; 
Richardson 2011). 
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In addition, tetraspanins physically associate with other transmembrane proteins 
such as cell-cell and cell-matrix adhesion molecules, growth factor receptors, and 
proteases and organize these transmembrane proteins into membrane complexes termed 
as tetraspanin webs, glycosynapses, or tetraspanin-enriched microdomains (TEMs), with 
which intracellular signaling proteins such as PI4K, PKC, and syntenin are associated 
(Berditchevski 2001; Berditchevski and Odintsova 2007; Helmer 2003; Liu and Zhang 
2006; Richardson 2011). The cell adhesion molecules present in TEMs include integrins, 
IgSF proteins, and cadherins (Liu and Zhang 2006; Miranti 2009; Richardson 2011). 
However, the biochemical and biophysical mechanisms by which tetraspanins form 
TEMs and regulate the activities of their associated transmembrane proteins remain 
largely unclear.   
 
 
1.5 THE INTRODUCTION OF TETRASPANIN CD82 
  
CD82 is a member of the tetraspanin superfamily, was initially discovered as a 
modulator for immune functions, and was then identified from metastatic rat prostate 
cancer cells as a suppressor of prostate cancer metastasis (Adachi et al 1996; Dong et al 
2005; Liu and Zhang 2006; Protzel 2008; Sridhar 2006; Yang et al 2001). CD82 has now 
been deemed as a metastasis suppressor for a wide variety of solid tumors (Abe et al 
2008; Adachi et al 1996; Dong et al 1996; Dong et al 1997; He at al 2005; Jee et al 2007; 
Liu and Zhang 2006; Miranti 2008; Protzel et al 2008; Sridhard and Miranti 2006; Tonoli 
and Barrett 2005; Yang et al 2001). The mechanism that governs CD82-mediated 
suppression of tumor metastasis, however, still remains largely unknown. 
 
 
1.5.1 The chromosomal locus of the CD82 gene 
 
The CD82 gene is located in the p11.2 region of the human chromosome. The 
gene spans ~8 Kb of genomic DNA and consists of 10 exons. The intron-exon 
organization of the CD82 gene is depicted in Figure 1-1. The CD82 gene contains 9 
introns and 10 exons. 
  
 
1.5.2 The expression and regulation of the CD82 gene 
 
The promoter is 795 base pairs. The coding region starts at base 25 of exon 3, 
spans exons 4-9 and into the first 75 base pairs of exon 10. The remainder of exon 10 
constitutes the 3’ untranslated region of CD82 as well as an Alu element.  The promoter 
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region of CD82 is CG rich, contains no TATA box, and has nine binding sites for the Sp1 
transcription factor and five binding sites for AP-2 (Dong et al. 1997). In addition to the 
wild type, the human CD82 gene produces two alternatively spliced variants. The 
variants, one and two, contain 9 exons, exon 6 or 8 have been deleted, respectively. 
 
 
1.5.3 The protein structure of CD82 
 
The CD82 protein is a 267 amino acid protein with a molecular weight of 30-90 
kDa, which is tissue specific and depends upon post-translational modification. CD82, 
being a member of the tetraspanin superfamily, contains 4 hydrophobic transmembrane 
domains, a large and a small extracellular loop, and two intracellular cytoplasmic tails, 
Figure 1-2. For the human CD82 proteins, each of the four transmembrane domains are 
formed by a hydrophic segment containing, 21,19,27,22, amino acid residues (Dong et al 
1997). The hydrophilic extracellular domains/loops 1 and 2 are composed of 21 
(positions 33-53) and 118 (positions 111-228) amino acids, respectively (Dong et al 
1997). The extracellular domain/loop 2 contains 6 cysteine residues, two of which are 
located in the conserved CCG motif (Dong et al 1997). The cysteine residues are 
predicted to form disulphide bonds and are important for proper protein folding and 
biological functions. Three putative glycosylation sites are located at residue/position 
129, 157, and 198, respectively (Dong et al 1997).  
 
The cytoplasmic tails of CD82 protein is short and contains 11 (positions 1-11) 
and 17 positions (251-267) amino acid residues, respectively (Dong et al 1997). Like 
other tetraspanins, CD82 is palmitoylated at the five cytoplasmic cysteine residues that 
are located proximal to the inner leaflet of the plasma membrane at residue/position 5, 74, 
83, 251, 253, respectively (Dong et al 1997). At the C-terminal cytoplasmic domain, 
there is a YSKV sequence, which falls into the category of the YXXΦ motif (Y: tyrosine 
residue, X: any amino acid residue, and Φ: hydrophobic amino acid residue with large 
side chains such as valine, leucine, and isoleucine (Dong et al 1997).  
 
 
Figure 1-1. The genomic organization of the CD82 gene. There are 10 exons and 9 
introns within the ~8 Kb CD82 gene. 
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Figure 1-2. The protein structure of the tetraspanin CD82. CD82 contains 4 
hydrophobic transmembrane domains, a large and a small extracellular loop, a small 
intracellular loop and two intracellular cytoplasmic tails. Located within the C-
terminal cytoplasmic tail of CD82 is a YSKV sequence that serves as a tyrosine based 
sorting motif. The large extracellular loop contains 6 cysteine residues, two of which 
are located in the conserved CCG motif which aids in proper protein folding and 
several sites for post-translational modification, three putative glycosylation sites and 
five proximal potential palmitoylation sites.  
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1.5.4 Tissue distribution of CD82  
 
CD82 is ubiquitously expressed in a wide variety of epithelial cells and is also 
expressed in endothelial cells (He et al 2005; Liu and Zhang 2006; Miranti 2009; 
Richardson 2011; Tonoli and Barrett 2005). Northern blot analysis revealed high 
expression of CD82 in the spleen, thymus, prostate,  ovary, small intestine, colon, 
placenta, lung, liver, kidney, and pancreas, relatively lower expression in the heart, brain, 
muscle,  and testis (Liu and Zhang 2006; Miranti 2009). In mice, CD82 was found in all 
tissue except the arterioles and brain (Miranti 2009).    
 
 
1.6 THE PATHOLOGICAL FUNCTIONS OF CD82: CD82 AND TUMOR 
PROGRESSION AND METASTASIS 
 
CD82 has been well documented to correlate with patient prognosis in various 
solid malignant tumors such as lung, pancreatic, breast, bladder, colon, esophageal, 
cervical, and endometrial cancers (Adachi et al 1996; Miranti 2009; Richardson 2011; 
Yang et al 2001; Uchida 1999). The tumor patients whose tumors express CD82 have a 
significantly greater chance of survival or longer survival time than those whose tumors 
have a decrease in or loss of CD82 expression (Liu and Zhang 2006; Marinti 2009; 
Tonoli and Barrett 2005). 
 
Inverse correlation of CD82 expression and metastasis has been observed in 
breast (Christgen 2008; Christgen 2009; Higashiyama et al 1998; Huang et al 1998), 
prostate (Bouras et al 1999; Dong et al 1996), liver (Guo et al 1998; Sun et al 1998), 
colon (Lombardi et al 1999; Maurer et al 1999; Wu et al 2004), stomach (Hionda 1998; 
Wu 2003;), pancreas (Friess et al 2001; Guo et al 1996), oral (Farhadieh et al 2004; 
Geradts et al 1999; Imai et al 2002; Uzawa et al 2002), ovary (Liu et al 2000; Schindl 
2008), endometrium (Briese 2008; Li et al 2011; Liu et al 2003; White et al 1998;), lung 
(Adachi et al 1996; Higashiyama 1998) thyroid (Chen et al 2004), SCC of the head and 
neck (Xiong et al 2005) esophagus (Miyazaki et al 2000), penile (Protzel et al 2008), and 
urothelial bladder cancers (Su et al 2004; Yu et al 1997).  
 
For example, CD82 is highly expressed in normal mammary epithelium, benign 
mammary gland tumor, and early malignant ductal carcinoma in situ (DCIs) lesions of 
breast cancer. Invasive ductal breast cancer and brain metastasis showed that CD82 
mRNA expression was significantly lower when compared to benign mammary gland 
tumors (Christgen et al 2008; Christgen et al 2009). In breast cancers, CD82 expression is 
correlated with estrogen receptor expression (Christgen et al 2008; Christgen et al 2009). 
CD82 expression is down regulated in ER-positive breast cancer cells and highly 
expressed in ER-negative breast cancer cells (Christgen et al 2009).  
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In prostate cancer, CD82 expression correlated with disease progression and 
disease free survival. 90% of patients who did not respond to androgen ablation therapy 
exhibited tumors with a loss of CD82 expression (Dong et al 1996). When CD82 
expression was restored in a highly metastatic rat prostate carcinoma cell line, the 
metastasis of prostate cancer was markedly suppressed (Dong et al 1995; Dong et al 
1996). 
 
The studies on other solid malignant tumors reached similar conclusions. In 
hepatocellular carcinoma, CD82 is down regulated at both the mRNA and protein levels 
(Guo et al 1998). CD82 expression correlates with intrahepatic metastasis but not with 
tumor size or expression of α-fetoprotein (Guo et al 1998; Sun et al 1998). In colorectal 
carcinoma, CD82 was down regulated upon the disease progression (Wu et al 2004). In 
gastric cancer, CD82 expression is inversely correlated with disease progression (Hinoda 
1998; Wu et al 2003). Down regulation of CD82 is frequently observed in ovarian cancer 
(Liu et al 2000; Schindl 2008).  
 
In Non Small Cell lung cancer, CD82 expression is inversely correlated with the 
disease progression and is therefore a good prognostic factor (Adachi et al 1996; 
Higashiyama et al 1998). Down regulation of CD82 in thyroid cancer is inversely 
correlated with patient prognosis (Chen et al 2004). CD82 expression is correlated with 
squamous cell carcinoma (SCC) of the head neck, lung, and cervix (Xiong et al 2005). In 
SCC, CD82 expression is not correlated with allelic loss, promoter hyper-methylation, 
gene mutation, or p53 regulation but was correlated with lymph node metastasis,   
disease-free survival and overall survival (Imai et al 2002; Xiong et al 2005). CD82 
expression can be used as a marker in penile and bladder cancer but not cervical cancer 
(Protzel et al 2008, Su et al 2004). Patients whose tumors exhibit CD82 have a 
significantly greater chance of survival than those whose tumors have a decrease in or 
loss of CD82 expression (Abe et al 2008; Protzel et al 2008; Sridhar and Miranti 2006; 
Yang et al 2001). CD82 has also been re-expressed in a highly metastatic prostate rat 
carcinoma cell line and was able to inhibit metastasis (Miranti 2009; Yang et al 2001).  
 
 
1.7 CD82-CONTAINING TETRASPANIN-ENRICHED MICRODOMAIN 
 
The mechanism by which CD82 inhibits metastasis has not been entirely 
established. It is believed that CD82 suppressive function is mediated by the association 
of other proteins. CD82 as well as other proteins are known to bind together and form 
tetraspanin enriched microdomains (Berditchevski 2001; Berditchevski and Odintsova 
2007; Helmer 2003; Liu and Zhang 2006; Richardson 2011). In fact, CD82 has been 
reported to be important for regulating cell signaling, cell adhesion, and 
sorting/trafficking of proteins to the cell surface (He et al 2005; Jee et al 2007; Liu and 
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Zhang 2006; Miranti 2009; Tonoli, 2005; Zhou et al 2004). One of the suggested 
mechanisms is that CD82 functions through its associations with integrins and other 
tetraspanins (Pols and Klumperman 2008; Zhou et al 2004). CD82 has been shown to 
associate with α2β1, α3β1, α4β1, α5β1, α6β1, and αLβ2 (Abe et al 2008; He et al 2005; 
Jee et al 2007; Liu and Zhang 2006; Miranti 2009; Sridhar 2006; Sridhar and Miranti 
2006; Tonoli and Barrett 2005). In Du145 prostate cancer cells, using function blocking 
antibodies, it was discovered that α6β1 integrin is responsible for the CD82-depenent 
cellular morphogenesis (He et al 2005).In another study, CD82 re-expression in a rat 
metastatic cell resulted in the reduction of α6 levels, as well as a reduction in cell 
adhesion. However in this study, it was observed that there was an increase in α6 
adhesion. However in this study, it was observed that there was an increase in α6 
internalization (Miranti 2009; Sridhar and Miranti 2006).  
 
CD82 has also been shown to associate with other tetraspanins such as CD9, 
CD81, CD63, CD151, and EWI-2 (Liu and Zhang 2006; Miranti 2009; Sridhar and 
Miranti 2006). Morever, growth factor receptors such as EGF receptor and HGF receptor 
c-Met and IgSF proteins such as EWI-2 were reported to associate with CD82. All of 
these tetraspanins and other CD82-associated proteins play key roles in the regulation of 
cell motility. 
 
 
1.8 CD82 AND CELL-CELL ADHESION 
 
CD82 may also function as a tumor suppressor through cell adhesion molecules, 
CAMs. CAMs mediate direct cell-cell adhesions (Abe et al 2008; Lodish 2004; Weinberg 
2007).The major cell-cell adhesion molecule for epithelial cells is epithelial cadherins or 
E-cadherins. E-cadherins forms adherence junctions with each other and act as 
mechanical linkages between cells. E-cadherin is thought to play a role in preventing 
tumor metastasis because it is commonly found to be down regulated in metastatic 
carcinomas (Abe et al 2008; Miranti, 2009). CD82 is located near adherens junctions 
which may facilitate its role in adhesion strengthening (Abe et al 2008). Abe et al 
reported that CD82 regulates E-cadherin-dependent cell adhesion by preventing 
dissemination in h1299 cells.  
 
 
1.9 THE TRAFFICKING OF CD82 
 
Besides plasma membrane, CD82 is also present in intracellular vesicles (Escola 
et al 1998; Hammond et al 1998). A recent study from our lab demonstrated that 1) CD82 
undergoes endocytosis and traffics to endosomes and lysosomes, 2) dynamin and clathrin 
are not essential for CD82 internalization, and 3) depletion or sequestration of sterol in 
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the plasma membrane markedly inhibited the endocytosis of CD82 (Xu et al 2009). In 
primary dendrtic cells, CD82 is recruited to C. neoformans-containing phagosomes in a 
phagosome acidification-independent manner or prior to the step of lysosomal fusion 
(Artavanis-Tsakonas et al 2011).   
 
Interestingly, CD82 and other tetraspanins are highly enriched in exosomes 
(Escola et al 1998), suggesting the putative roles of CD82 in exosome formation and 
release. Notably, Chairoungdua et al recently showed that CD82 suppresses beta   
catenin-mediated Wnt signaling by inducing the exosomal release of beta catenin 
(Chairoungdua et al 2010).  
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CHAPTER 2.    REGULATION OF TRAFFICKING BY THE YXXΦ MOTIF OF 
CD82 
 
 
2.1 INTRODUCTION 
 
Some tetraspanins such as CD9 and CD81 are exclusively expressed on the cell 
surface whereas others such as CD82 contain a large intracellular pool, in addition to that 
found on the plasma membrane. Immuofluorescent studies revealed that CD82 proteins 
are present at the cell peripheries and intracellular vesicles (Richardson 2011; Xu et al 
2010). Electron microscopic and proteomics studies showed that CD82 proteins are also 
enriched in multi-vesicular bodies (MVBs) and exsosomes (Miranti, 2009; Richardson 
2011). These observations strongly argue for the active trafficking of CD82 proteins 1) 
between the plasma membrane and endosomal/lysosomal compartments and 2) 
extracellular environment.  
 
Indeed, an earlier study from our lab demonstrated that CD82 undergoes 
endocytosis and the internalized CD82 traffics to late endosomes and lysosomes (Xu et al 
2009). Interestingly, dynamin and clathrin are not essential for CD82 internalization (Xu 
et al 2009), suggesting that CD82 is internalized through a clathrin-independent 
mechanism. The perturbation, depletion, or sequestration of cholesterol in the plasma 
membrane markedly inhibited the endocytosis of CD82 (Xu et al 2009), suggesting that 
CD82 endocytosis depends on cholesterol. The study also found that CD82 endocytosis is 
distinct from macropinocytosis and other dynamin-independent pinocytosis (Xu et al 
2009). Functionally, the lipid-dependent endocytosis of CD82 appears to alleviate  
CD82-mediated inhibition of cell migration (Xu et al 2009). 
 
Notably, CD82 contains an YSKV sequence in its C-terminal cytoplasmic 
domain. This YSKV sequence falls into the category of the YXXΦ sorting motif, in 
which Y is a tyrosine residue, X can be any amino acid residue, and Φ represents bulky 
hydrophobic amino acid residues such as L, I, and V (Marks et al 2007). As described 
above in clathrin-dependent endocytosis, the cytoplasmic domains of transmembrane 
molecules usually contain conserved internalization motifs such as the YXXΦ sequence. 
Since CD82 endocytosis appears to be independent of the YXXΦ motif, whether this 
motif plays roles in the targeting CD82 to endosomal and lysosomal compartments or to 
exosomes remains to be determined. More importantly, whether this motif plays a role in 
the function of CD82, such as the inhibition of cell movement needs to be assessed. 
 
To determine whether the YSKV sequence of CD82 is involved in the regulation 
of its intracellular trafficking and biological functions, we mutated the tyrosine based 
sorting motif of CD82. After establishing the stable transfectants of this mutant in PC3 
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and Du145 human metastatic prostate cancer cells, we examined the role of CD82 YXXΦ 
motif in the endocytosis, recycling, lysosomal targeting, and exosomal release of CD82. 
We also investigated the roles of CD82 YXXΦ motif in the surface expression and 
trafficking of CD82-associated proteins as well as the cell adhesion proteins important for 
cell movement. 
 
Our studies suggest that the tyrosine-based sorting motif of CD82 is not important 
for the internalization of CD82 proteins but regulates the intracellular trafficking such as 
lysosomal targeting, recycling, and exosomal release of CD82 proteins. 
 
 
2.2 MATERIALS AND METHODS 
 
 
2.2.1 Materials 
 
The monoclonal antibodies (mAbs) used in this study were human CD82 mAb 
TS82b (kindly provided by Dr. Eric Rubenstein), CD63 mAb (Ancell), EEA-1 mAb (BD 
Biosciences), LBPA mAb (Echelon), murine IgG2b (Sigma), and integrin β1 mAb 
TS2/16. Fluorescent reagents include FITC-conjugated goat-anti-mouse IgG (Sigma), 
fluorescent probes Alexa-488 and Alexa-594 (Invitrogen), and LysoTracekr Red DND99 
(Invitrogen). Other reagents include detergents Brij 97 and 98 (Sigma), NP-40 (Fluka), 
ultracentrifuge tubes (Beckman), lipofectanine 2000 (Invitrogen), Geneticin or G418 
(Gibco/Life Technology), Chemiluminesence reagents (Perkin Elmer), goat serum 
(Gibco/Life Technology), DMEM (Gibco/Life Technology), x-ray film (Perkin Elmer), 
and paraformaldehyde (Fisher).  
 
 
2.2.2 Cell culture 
 
PC3 and Du145 human metastatic prostate cancer cells were obtained from 
ATCC and cultured in DMEM, supplemented with 10% fetal bovine serum, 100 units/ml 
penicillin, 100µg/ml streptomycin, and 2 mM L-glutamine,  at 37° in a 5% CO2 
incubator. 
 
 
2.2.3 Cells and transfectants 
 
The CD82 wild type (WT) and CD82 YVAA mutant constructs were generated 
by fusing CD82 cDNA with a eukaryotic expression vector (pcDNA 3.1+ or pCRuni). 
Briefly, the CD82 YVAA mutant was generated by simultaneously replacing the 
Tyrosine and Valine residues in the YSKV sequence at the C-terminal cytoplasmic 
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domain of the wild type CD82 with the Alanine residues through PCR. The full length 
cDNAs encoding human wild type and YVAA mutant CD82 were constructed into 
pcDNA 3.1+ or pcrUNI vectors, respectively, through the XbaI and HindIII sites. The 
sequences of CD82 coding frame were confirmed by DNA sequencing.  
 
PC3 and DU145 cells were transfected with the plasmid DNA using 
Lipofectamine 2000 (Invitrogen) and selected under geneticin (g418) at a concentration 
of 1.0 and 0.5 mg/ml, respectively. The G418-resistant clones were pooled together, and 
the CD82-positive clones were obtained by flow cytometric cell sorting. The sorted 
CD82-positive clones were maintained as the CD82 WT or YVAA stable transfectants.    
 
 
2.2.4 Western blot 
 
Cells were lysed with 1% Brij 97 and/or 1% Nonidet P-40 lysis buffer at 4 °C for 
1 h. Insoluble material was removed by the centrifugation at 14,000 × g for 15 min. The 
cell lysates were mixed with Laemmli sample buffer and heated at 95 °C for 5 min. The 
proteins were separated by SDS-PAGE and electrically transferred to nitrocellulose 
membranes (Bio-Rad). The membranes were sequentially blotted with primary mAb and 
horseradish peroxidase-conjugated second Ab (Sigma), followed by chemiluminescence 
(Perkin Elmer Life Sciences). 
 
 
2.2.5 Flow cytometry 
 
For flow cytometry, confluent cells were detached, washed with 1xPBS, and 
blocked with 2% goat serum on ice for 1 hour to block the non-specific binding. Cells 
were incubated with 1µg/ml of primary mAb such as CD82 mAb TS82b, integrin β1 
mAb TS2/16, or murine IgG2b on ice for 1 hour followed by PBS washes. The cells were 
then labeled with appropriate flurochrome-conjugated secondary Ab on ice for 30 mins 
followed by extensive PBS washes. The cell surface expressions of the proteins were 
analyzed using a FACS Calibur flow cyotmeter (BD Biosciences). 
 
 
2.2.6 Internalization and recycling assays 
 
The internalization of CD82 was examined by an antibody uptake assay as 
previously described (Liu et al 2007). Briefly, adherent cells were incubated with 1 µg/ml 
of CD82 mAb TS82b on ice for 1 hr. The unbound mAb was removed by the washes 
with ice cold media, and the cells were incubated at 37° in 5% CO2 for 1 hr for 
internalization. The cell surface-bound or un-internalized antibody was removed with 
acidic washes (0.1M glycine buffer, pH 2.7). The cells were fixed, permeablized, and 
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blocked with 20% goat serum. The cells were labeled with flurochrome-conjugated 
secondary antibody, extensively washed, mounted with FluroSave solution, and 
examined with either fluorescent microscope or flow cytometry.  
 
The recycling of CD82 was examined by the antibody uptake followed by the 
antibody retrieval and removal at the cell surface. Briefly, the cells were incubated with 1 
µg/ml of CD82 mAb TS82b on ice for 1 hr. The unbound mAb was removed by washes 
with ice cold media followed by 1 hr incubation at 37°. The cell surface-bound, un-
internalized mAb was removed with acidic washes (0.1M glycine buffer, pH 2.7), and 
then the cells were re-incubated with medium at 37° for 1 or 3 h to allow the recycling of 
the internalized mAb. The cells were acid washed, fixed, permeablized, and blocked for 
non-specific binding with 20% goat serum. The cells were then labeled with Alexa      
594-conjugated secondary antibody, extensively washed, and then either mounted with a 
FluroSave solution for microscopic analysis or examined directly using flow cytometry.  
 
 
2.2.7 Intracellular trafficking of CD82 
 
The intracellular tracking of CD82 proteins to endosomal and lysosomal 
compartments was assessed by analyzing the co-distribution of CD82 with the 
intracellular organelle markers at the steady state.  
 
For the co-localization of CD82 with CD63, the cells were fixed, permeablized, 
blocked, and then incubated with FITC-conjugated CD63 mAb and Alexa                   
594-conjugated CD82 mAb TS82b for 1.5 hours, followed by extensive PBS washes, and 
mounted for microscopic analysis.  
 
For the co-localization of CD82 with LysoTracker, the cells were incubated at 37° 
in 5% CO2 for 10 minutes in the presence of 0.25µg/ml of LysoTracker Red DND99, 
followed by rinsing with fresh media. The cells were fixed, permeablized, blocked, and 
incubated with Alexa 488-conjugated CD82 mAb TS82b for 1.5 hours, extensively 
washed with PBS, and mounted for microscopic analysis.  
 
For the co-localization of CD82 with lysobiphosphatic acid (LBPA), a double 
staining procedure was applied. The cells were fixed, permeablized, blocked, and 
incubated with 1µg/ml of LBPA followed by labeling with Alexa 594-conjugated 
secondary antibody for 1 hour and extensive washes. The cells were further blocked with 
an isotype matched mAb for 1 hour to saturate the binding sites of the secondary Ab. The 
cells were then incubated with Alexa 488-conjugated CD82 mAb TS82b for 1.5 hours, 
extensively washed with PBS, and mounted for microscopic analysis. 
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For the co-localization of CD82 with Rab 11 WT or dominant negative mutant, 
the transfectant cells were transiently transfected with Rab 11 WT-GFP or Rab 11 
dominant negative mutant-GFP constructs and grown for 48 hours. The cells were fixed, 
permeablized, blocked with 20% goat serum in PBS, incubated with Alexa                  
594-conjugated CD82 mAb TS82b for 1.5 hours, extensively washed with PBS, and 
mounted for confocal microscopic analysis as described at following.  
 
For the co-localization of integrins α2, α3, α5, and α6, we followed the 
internalization assay, see section 2.2.6. Briefly, adherent cells were incubated with 1 
µg/ml of integrin α2 mAb IIE10, integrin α3 mAb A3X8, α5 mAb BIIG2, and integrin α6 
A6BB mAb on ice for 1 hr. The unbound mAb was removed by the washes with ice cold 
media, and the cells were incubated at 37° in 5% CO2 for 1 h for internalization. The cell 
surface-bound or un-internalized antibody was removed with acidic washes (0.1M 
glycine buffer, pH 2.7). The cells were fixed, permeablized, and blocked with 20% goat 
serum. The cells were labeled with an Alexa-594-conjugated secondary antibody, 
extensively washed. The cells were then blocked with an IgG isotype matched mAB and 
further probed with a directly conjugated Alexa-488CD82, TS82b, mAb, followed by 
extensive washing. The cells were then mounted with FluroSave solution, and examined 
with either fluorescent microscope or flow cytometry.  
 
For the quantification of co-localization, the Ziess LSM software was used to 
measure the amount of CD82 staining that is co-localized with the markers of endosomal 
and lysosomal compartments as described above. 
 
 
2.2.8 Fluorescent and confocal microscopy 
 
The cells were fixed, permeablized, blocked, and incubated with Abs and 
fluorescent probes as described above. For immunofluorescence analysis, the cells were 
examined with an Axiophot fluorescent microscope (Carl Zeiss) at the magnification of 
63x, and the images were captured using an optronics digital camera. For confocal 
microscopic analysis, cells were examined using a LSM 510 laser scanning microscope 
(Carl Zeiss) using excitation lasers for the 488 and 594 nm wavelengths and a 100x/1.4 
objective. 
 
 
2.2.9 Exosome isolation 
 
Exosomes were isolated as previously described (Nazarenko et al 2010). Briefly, 
10 x 106 PC3 cells or 20 x 106 Du145 cells were grown overnight in complete DMEM, 
washed twice with PBS, replenished with incomplete DMEM, and further grown for    
48-72 hours. The conditioned medium (or culture supernatant) was subjected to the 
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following differential centrifugation steps: 1) 500 x g for 10 minutes twice, 2) 2,000 x g 
for 20 minutes, 3) 10,000 x g for 30 minutes, and 4) 100,000 x g for 90 minutes. The 
pellets from last centrifugation were washed with excessive amounts of PBS and 
centrifuged at 100,000xg for 90 minutes to obtain the purified exosomes.  
 
For protein analysis, 30µl of medium was removed after each of the first 5 
centrifugation step and the purified exosomes were resuspended in 100µl of PBS, 
dissolved in Laemmli sample buffer, heated at 95 °C for 5 min, separated by SDS-PAGE, 
and then electrically transferred to nitrocellulose membranes (Bio-Rad). The membranes 
were sequentially blotted with primary mAb and horseradish peroxidase-conjugated 
second mAb (Sigma), followed by chemiluminescence (Perkin Elmer Life Sciences).  
 
 
2.3 RESULTS 
 
 
2.3.1 Generation of stable CD82 WT and CD82 YVAA transfectants in PC3 and 
Du145 cells 
 
We used a PCR-based, site-directed mutagenesis approach to mutate the   
tyrosine-based internalization/sorting motif at the CD82 C-terminal domain from the 
YSKV sequence to the ASKA sequence, referred to as YVAA mutant hereafter. Using 
lipofectamine-based transfection method, we generated MOCK, CD82 WT and CD82 
YVAA stable transfectants in PC3 and Du145 human metastatic prostate cancer cells. 
Compared to the PC3-MOCK cells, PC3-CD82 WT and -CD82 YVAA transfectants 
expressed significantly more CD82 proteins both at the cell surface and in total cells. 
PC3-CD82 WT and -CD82 YVAA transfectants express equivalent amounts of total 
cellular CD82 proteins, as analyzed by Western blot, as shown in Figure 2-1, and similar 
levels of CD82 at the cell surface, as measured by flow cytometry, as shown in  
Figure 2-2. 
 
 
2.3.2 Mutation of the YXXΦ motif of CD82 did not alter the steady state 
distribution of CD82 
 
The subcellular distribution and endosomal and lysosomal localization of CD82 
likely plays a role in its motility-suppressive function. We analyzed the steady state 
localization of CD82 WT and CD82 YVAA mutant. The immunofluorescence analysis 
revealed that the mutation in the internalization/sorting motif of CD82 did not alter the  
subcellular distribution of CD82 proteins, when comparing the immunofluorescence 
staining of CD82 WT and CD82 YVAA in either non-confluent or confluent cell growth 
stages, as shown in Figure 2-3. 
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Figure 2-1. The expression of CD82 proteins in PC3 transfectant cells were  
analyzed by Western blot. PC3-Mock, -CD82 WT, and -CD82 YVAA cells were 
detached and lysed in 1% NP-40 lysis buffer. Equal amounts of cell lysate were 
resolved by SDS-PAGE. Proteins were transferred to nitrocellulose membrane  
and then probed with CD82 mAb TS82b and β tubulin mAb. β tubulin served as  
a loading control. 
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Figure 2-2. The expression of CD82 proteins at the surface of PC3 transfectant          
cells were analyzed by flow cytometry. PC3-MOCK, -CD82 WT, and -CD82 YVAA 
transfectant cells were detached, incubated with a negative control mAb                        
(murine IGg2b), a CD82 mAb (TS82b), and a positive control mAb (β1 integrin mAb 
TS2/16) and then analyzed by flow cytometry after a FITC-conjugated second Ab 
incubation. The mean fluorescence intensity of CD82 staining for PC3-MOCK,  
PC3-CD82 WT, and PC3-CD82 YVAA transfectant cells was 243, 1710, and 1578, 
respectively. 
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Figure 2-3. The mutation of the YXXΦ motif of CD82 does not result in an 
alteration of the steady state distribution of CD82 proteins in PC3 cells.           
PC3 -MOCK, -CD82 WT, and -CD82 YVAA transfectant cells were fixed, 
permeablized, blocked for non-specific binding, and then incubated with the Alexa 
488 directly-conjugated CD82 mAb (TS82b). The cells were extensively washed and 
mounted. Images were captured by using a fluorescent microscope equipped with a 
digital camera.  
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2.3.3 Mutation of the YXXΦ motif of CD82 does not abrogate CD82 internalization 
 
The internalization and subsequent trafficking of transmembrane proteins regulate 
their function. CD82 has been shown to alter the function of the protein that are 
sequestered into TEMs and has also been shown to prevent the retraction of cells during 
cell migration. The YXXΦ motif is a determinant for the endocytosis of many 
transmembrane proteins. The role of this motif in CD82 endocytosis has not been 
experimentally addressed. 
 
As shown in Figure 2-4, the mutation of the YXXΦ motif of CD82 did not inhibit 
the internalization of CD82 and could even lead to a slight increase in CD82 
internalization. The quantification of CD82 endocytosis assayed by either 
immunofluorescence or flow cytometry came to the same conclusion, Figure 2-5. In 
Figure 2-5A, the average numbers of CD82-positive, intracellular vesicles after 1-hr 
endocytosis assayed by immunofluorescence is presented. Figure 2-5B depicts the mean 
fluorescence intensity of the intracellular CD82 staining after 1 hr endocytosis. 
 
 
2.3.4 The mutation of the YXXΦ motif of CD82 alters CD82 recycling   
 
Since the YXXΦ motif of CD82 is not responsible for regulating the 
internalization of CD82, it may regulate the trafficking of CD82 back to the plasma 
membrane or the recycling process of CD82. The results from the immunofluorescence 
based recycling assay revealed that 1) there is a slow pace in recycling of CD82 proteins 
and 2) there is an accumulation of the CD82 YVAA mutant proteins within the 
intracellular compartments in a time-dependent manner, as shown in Figure 2-6. 
 
The images presented in Figure 2-6 shows that similar numbers of CD82-positive 
intracellular vesicles can be found between PC3-CD82 WT and -CD82 YVAA cells after 
1 hour recycling. However, in contrast to CD82 WT-positive intracellular vesicles, there 
is an increase in the number of CD82 YVAA-positive vesicles within the cells after an 
additional 2 hours of recycling.  
 
The quantitative data presented in Figure 2-7 represents the average levels of 
internalized CD82 proteins that were still remained inside PC3 transfectant cell after 1 
and 3 hr recycling. In Figure 2-7A, the quantitative data of recycling were obtained from 
the immunofluorescence images. We also measured the CD82 recycling using the flow 
cytometry-based recycling assay. The histogram in Figure 2-7B represents the mean 
fluorescent intensity (MFI) of the CD82 proteins staining that remained intracellularly 
after the given periods of recycling. The data obtained from the flow cytometry based 
recycling assay are quite consistent with the results obtained from the  
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Figure 2-4. The mutation of the YXXФ motif of CD82 does not significantly 
reduce CD82 internalization. The PC3-Mock, -CD82 WT, and -CD82 YVAA 
transfectant cells were plated onto glass coverslips and grown overnight in complete 
media. The cells were incubated with CD82 mAb TS82b at 4°C for 1 h. The cells 
were then allowed to internalize the bound mAb by the incubation at 37°C for 1 h, 
followed by acid washes to remove un-internalized mAbs. The cells were fixed, 
permeablized, and incubated with Alexa 594-conjugated 2nd mAb. The cells were 
then analyzed using a fluorescent microscope. 
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Figure 2-5. The mutation of the YXXФ motif of CD82 does not reduce but may 
enhance CD82 internalization. PC3-MOCK, -CD82 WT, and -CD82 YVAA 
transfectant cells were plated onto glass coverslips and grown overnight. Cells were 
incubated with CD82 mAb TS82b at 4°C for 1 h. Cells were then allowed to 
internalize the bound mAb at 37°C for 1 h, acid-washed, fixed, permeabilized, and 
incubated with a Alexa 594-labeled secondary antibody. A, the endocytosis of CD82 
was assessed by immunofluorescence using a fluorescent microscope; the 
quantification was performed by counting the number of CD82-positive intracellular 
vesicles per cell. In each experiment, 50 CD82-positive cells were quantified per 
transfectant. B, the endocytosis of CD82 was assessed for the mean fluorescence 
intensity of the vesicles inside the cell by flow cytometry. The histograms represent 
the average and standard deviation of 4 experiments. 
  A B 
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Figure 2-6. The YXXФ motif regulates CD82 recycling. PC3-Mock, -CD82 WT 
and -CD82 YVAA transfectant cells were plated onto glass coverslips and grown 
overnight in complete media. After the 60-min incubation of CD82 mAb at 37°C for 
endocytosis and three acid-washes at RT for the removal of un-internalized mAb, the 
transfectants were placed back at 37°C for 1 or 3 h for recycling. The cells were then 
further treated with acid-washes to remove the recycled mAbs. The cells were then 
fixed, permeabilized, and incubated with 2nd mAb. Immunofluoresence images of 
the recycling assay were captured using a fluorescence microscope (63x). 
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Figure 2-7. Mutation of the YXXФ motif regulates CD82 recycling. PC3-Mock,   
-CD82 WT and -CD82 YVAA transfectant cells were plated onto glass coverslips 
and grown overnight in complete media. After 60-min incubation 37°C for 
endocytosis followed by acid-washing, the transfectants were placed back at 37°C 
for 1 or 3 h for recycling followed by acid-washing. The cells were then fixed, 
permeabilized, and incubated with 2nd mAb. A, immunofluoresence images of the 
recycling assays were acquired by a fluorescence microscope (63x), and CD82 
endocytosis and recycling were quantified by counting the number of CD82-positive 
intracellular vesicles per cell (left panel). In each experiment, 50 CD82-positive cells 
were counted per transfectant. The histogram represents the number of CD82 
positive vesicles remaining inside the cells after recycling divided by the number of 
vesicles per cell after internalizatoin. B, the recycling of CD82 in PC3 transfectants 
was also analyzed in flow cytometry with the same principle and procedures 
described above (right panel). The FACS recycling data were normalized by dividing 
the mean flouresnece intensity after 1 hr or 3 hr by the mean flouresnece intensity 
after internalization. Each histogram represents the mean and standard deviation of 
recycling from four experiments. 
 
  A B 
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immunofluorescence-based recycling assay. For CD82 WT cells, CD82 proteins were  
recycled slowly and became gradually decreased intracellulary during 3 hour recycling 
period. For CD82 YVAA cells, the intracellularly remained CD82 mutant proteins even 
became increased after 3 hour recycling.  In addition, in Du145-Mock, -CD82 WT, and   
-CD82 YVAA transfectants, we obtained the same results using the flow cytometry based 
recycling assay (data not shown).  
 
The recycling data suggests that the function of the YXXΦ motif of CD82 is to 
regulate its intracellular trafficking, specifically recycling. The increase of intracellular 
CD82 YVAA mutant proteins after 3-hour recycling suggests that some of the 
internalized CD82 YVAA mutant proteins may traffic to the acidic vesicular 
compartment and therefore cannot be detected by CD82 mAb, the probe for both 
endocytosis and recycling assays. The CD82 YVAA mutant proteins may gradually 
traffic out of the acidic vesicular compartment after the 3 hour incubation at 37 oC for 
recycling and subsequently become detectable by CD82 mAb. As a result, more CD82 
staining was found intracellularly in CD82 YVAA transfectant after 3-hour recycling 
than after endocytosis or 1-hour recycling. Nevertheless, the mutation in the YXXΦ motif 
of CD82 appears to redirect CD82 from the recycling back to the plasma membrane.  The 
data presented in Figure 2-7 represents the average numbers or levels of CD82-positive 
intracellular vesicles per cell after 1 and 3 hour recycling. In Figure 2-7A, the quantitated 
data of recycling were obtained from the immunofluorescence images. Figure 2-7B 
represents the mean fluorescent intensity of the CD82 staining that remained intracellular 
after recycling. This data suggests that the function of the YXXΦ motif of CD82 is to 
regulate its intracellular trafficking, specifically recycling.   
  
 
2.3.5 The mutation of the YXXΦ motif does not disrupt the trafficking of CD82 to 
the late endosomal and lysosomal compartments     
 
The YXXΦ motif is not only important for the regulation of internalization but 
also an important regulator of lysosomal trafficking. CD63 is a well established marker  
for the late endosomal and lysosomal compartments. We analyzed the co-localization of 
CD82 with the CD63-positive compartments, as shown in Figure 2-8. 
Immunofluorescence images revealed that both CD82 WT and CD82 YVAA are able to 
localize to the CD63 positive compartments to  similar extents, as shown in Figure 2-8A. 
The co-localization analysis revealed that 36 percent of both CD82 WT and YVAA were 
co-localized with CD63 in the late endosomal and lysosomal compartments,             
Figure 2-8B. 
 
Since CD63 is a marker for the late endosome and lysosome, we further analyzed 
the trafficking of CD82 to each of the separate compartments. We analyzed the  
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Figure 2-8. The mutation of the YXXФ motif does not disrupt CD82 trafficking 
to CD63-positive late endosomal and lysosomal compartments. A, the               
PC3 -MOCK -CD82 WT and -CD82 YVAA transfectant cells were plated onto glass 
coverslips and grown overnight in complete media. The cells were fixed, 
permeablized, and then incubated with Alexa 594-conjugated CD82 mAb TS82b and 
FITC-conjugated CD63 mAb. Digital images were acquired under a confocal 
microscope. B, The quantifications of CD82 colocalization with CD63 were carried 
out using LSM image software. Histogram represents the mean and standard deviation 
of colocalization levels from three experiments. 
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colocalization of CD82 with lysobiphosphatic acid (LBPA), a late 
endosome/multivesicular body marker, Figure 2-9. As shown in Figure 2-9A,  
immunofluorescence analysis indicating that CD82 WT and CD82 YVAA both            
co-localize with LBPA at similar levels. Co-localization analysis, using LSM software, 
reveals that 32 and 35 percent of CD82 WT and YVAA localizes to the late 
endosome/multivesicular body, respectively, Figure 2-9B.  
 
We also analyzed the localization of CD82 to lysosomes using a lysosome probe, 
LysoTracker. As shown in Figure 2-10, we discovered that markedly more CD82 YVAA 
proteins were localized to the acidic, lysosomal, compartments compared to CD82 WT.  
Figure 2-10A reveals that more CD82 WT proteins appear to localize to the cell 
periphery whereas the CD82 YVAA localizes mainly to the intracellular compartments. 
Co-localization analysis, using LSM software, revealed that 12 and 43 percent of CD82 
WT and YVAA co-localize with LysoTracker, respectively, Figure 2-10B. 
 
These results indicate that the function of the YXXΦ motif of CD82 is not to 
drive CD82 trafficking to the multivesicular bodies and lysosome to be degraded. Our 
studies showed that the function of the YXXΦ motif of CD82 is to have CD82 recycled 
back to the plasma membrane or released into the extracellular space of the cells.      
 
 
2.3.6 CD82 proteins are likely recycled by Rab 11 recycling endosomes and the 
YVAA mutation reduced CD82 trafficking to Rab 11 recycling endosomes 
 
CD82 WT and YVAA mutant proteins have been found on the plasma membrane, 
in late endosomal compartments, and in lysosomal compartments. The trafficking of a 
transmembrane protein to late endosomes typically has two different fates: 1) being 
recycled back to the plasma membrane with the aid of Rab 4 or Rab11 or 2) being 
secreted to the extracellular milieu of the cells via exosomes.  
 
Rab 4 and Rab 11 are the primary proteins responsible for recycling intracellular 
proteins back to the plasma membrane. Our early study revealed that significantly more 
CD82 proteins are localized in Rab 11 recycling endosomes than in Rab 4 recycling 
endosomes (Xu et al 2009), suggesting that CD82 is recycled through Rab 11 recycling 
endosome.  
 
To investigate the recycling mechanism of CD82, we transiently expressed Rab 4 
and Rab 11 wild type and dominant negative mutants in PC3 CD82 transfectants and 
discovered that CD82 uses the Rab 11 pathway for recycling back to the plasma  
membrane. Less than 10% of CD82 WT proteins colocalizes with Rab 4 at steady state 
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Figure 2-9. The mutation of the YXXФ motif does not disrupt CD82 trafficking 
to the multivesicular bodies (MVBs) of the cells. A, The PC3-MOCK -CD82 WT 
and -CD82 YVAA transfectant cells were plated onto glass coverslips and grown 
overnight in complete media. The cells were fixed, permeablized, and then incubated 
with Alexa 488-conjugated CD82 mAb TS82b and Alexa 594-conjugated LBPA 
mAb. The images were captured using a confocal microscope. B, the quantifications 
of CD82 colocalization with LBPA were carried out using LSM image software. 
Histogram represents the mean and standard deviation of colocalization levels from 
a total of 50 cells and three experiments.  
MOCK CD82 WT CD82 YVAA  A 
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Figure 2-10. Mutation of the YXXФ motif directs CD82 trafficking to the lysosomal 
compartments of the cells. A, The colocalization of CD82 with LysoTracker. The  
PC3-MOCK -CD82 WT and -CD82 YVAA transfectant cells were plated onto glass 
coverslips, grown overnight in complete media, and incubated with Texas                 
Red-conjugated LysoTracker at 37°C for 20 min. The cells were fixed, permeabilized, 
probed with Alexa 488-conjugated CD82 mAb TS82b. The images were captured using 
a confocal microscope. Red, LysoTracker; Green, CD82. B, The quantifications of 
CD82 colocalization with LysoTracker were carried out using LSM image software. 
Histogram represents the mean and standard deviation of colocalization levels from a 
total of 50 cells and three experiments. 
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 whereas approximately 30% of CD82 WT colocalizes with Rab 11 (data not shown).   
 
Furthermore, we observed that, after 90 minutes of internalization, a majority of 
CD82 WT is recycled; however quite a few  CD82-positive vesicles still remained within 
the CD82 YVAA cells, as shown Figure 2-11. When the CD82 endocytosis was 
analyzed in the PC3 transfectant cells that express wild type or  a dominant         
negative-mutant of Rab 11, the CD82 WT-positive vesicles accumulated when the 
dominant negative-mutant of Rab 11 was expressed, and CD82 WT proteins were 
colocalized readily with the Rab 11 dominant-negative mutant, Figure 2-11.  There is not 
an alteration in accumulation of CD82 YVAA proteins in the cells that express the Rab 
11 dominant-negative mutant, compared to the cells that express Rab 11 wild type, 
Figure 2-11A. The co-localization of CD82 proteins with either Rab 11 WT or Rab11 
dominant-negative mutant becomes markedly diminished  upon the YVAA mutation as 
shown in Figure 2-11B. This data strongly suggest that Rab 11 is responsible for CD82 
recycling once CD82 reaches the late endosomes, and the YXXΦ motif facilitates the 
trafficking of CD82 to Rab 11-positive recycling endosomes.  
 
 
2.3.7 CD82 proteins are released from PC3 cells via exosomes   
 
To investigate whether CD82 can be released via the exosomal compartment and 
determine the effect of YVAA mutation on exosomal release, we performed differential 
centrifugation on conditioned media from PC3 transfectant cells and found that CD82 
WT proteins are highly enriched in the purified exosomes, compared to CD82 YVAA 
mutant proteins, as shown Figure 2-12. Flotillin, an exosomal marker, was used as a 
loading control and also displayed the exosomal enrichment In Figure 2-12A, the levels 
of flotillin reflect that the same amount of protein from the total cell lysate, conditioned 
media, and isolated exosomes was loaded from each transfectant.  
 
In Figure 2-12B, we observed that transferrin receptor was not released via 
exosomes as predicted and therefore serves as the negative control. Figure 2-12B also 
reveals that tetraspanin CD81 is enriched in and released via exosomes and serves as a 
positive control. Similar levels of CD82 expression between PC3-CD82 WT and -CD82 
YVAA transfectants can be found from total cell lysates, as shown in Figure 2-12C. 
Most importantly, as shown in Figure 2-12D, this experiment revealed that, in the 
purified exosomes, i.e., fraction 7, CD82 WT proteins were highly enriched and much 
more abundant compared to CD82 YVAA mutant proteins in the same fraction.     
 
Taken together, this set of data suggest that the function of the YXXΦ motif of 
CD82 is to direct 1) the trafficking of CD82 from the plasma membrane to the late 
endosome/multi-vesicular body, 2) the recycling of CD82 from late endosomes back to   
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Figure 2-11. Mutation of the YXXФ motif disrupts CD82 trafficking to the Rab 11 
positive compartments. A, For the co-localization of CD82 with Rab 11 WT or 
dominant negative mutant, the PC3 transfectant cells were transiently transfected with 
Rab 11 WT-GFP or Rab 11 dominant negative mutant-GFP.  After 48 hours, the 
cells were fixed, permeablized, blocked, incubated with Alexa 594-conjugated TS82b 
for 1.5 hours, washed, and then mounted. The images were captured using a confocal 
microscope. B, Quantifications of the colocalization of CD82 with Rab 11 WT or 
dominant negative mutant was carried out using LSM image software to assess the 
overlapped fluorescent intensities of CD82 and Rab11 staining. The histogram 
represents the average and standard deviation of three experiments.   
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Figure 2-12. The effects of CD82 overexpression and CD82 YVAA mutation on 
exosomal content. The PC3-Mock, -CD82 WT, and -CD82 YVAA mutant 
transfectant cells were grown in incomplete DMEM for 48-72 hours. The culture 
supernatants were harvested and subjected to differential centrifugations for exosome 
purification (see the details in “Materials and Methods”). The exosome preparation 
and total cell lysate samples were dissolved in Laemmli sample buffer, separated by 
SDS-PAGE, and analyzed in Western blot. A, to ensure that we obtained purified 
exosomes, we probed the centrifugation fractions for the exosomal marker flotillin. 
Fraction 1 represents the total amount contained within the media released from the 
cells, fraction 7 represents the isolated exosome fraction from the 100,00x g 
centrifugation step. B, we also analyzed the 100,00x g fraction for tetraspanin CD81, 
a protein enriched in exosomes, and transferrin a proteins absent from exosomes, as 
shown in top panel and bottom panel, respectively. C, we also analyzed total cellular 
CD82 expression from whole cell lysate (top panel) and the CD82 found in the 
100,00x g fraction (bottom panel). D, The band intensity for the CD82 proteins 
released with exosomes, as shown in the bottom panel of C, was quantified using 
ImageJ analysis. 
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the plasma membrane, and 3) the releases of CD82 via exosomes. 
 
 
2.3.8 The mutation of the YXXΦ motif of CD82 does not affect the cell surface 
expression levels of CD82-associated tetraspanins but up-regulates the cell surface 
expression levels of integrins α2β1, α3β1, and α5β1 
 
CD82 and other tetraspanins sequesters other cell surface proteins such as 
integrins to form TEMs at the plasma membrane (Liu and Zhang 2006; Richardson 
2011). It is suggested that the motility-suppressive function of CD82 is mediated by its 
associated transmembrane proteins that are located within the CD82-positive TEMs 
(Berditchevski, 2001; Berditchevski and Odintsova 2007; Helmer 2003; Liu and Zhang 
2006; Richardson 2011). The alteration in CD82 trafficking due to the YVAA mutation 
may also affect the steady-state cellular distribution and trafficking of CD82-associated 
TEM components. 
 
Therefore we analyzed the cell surface expression of CD82-associated 
tetraspanins and integrins by flow cytometry, and the results are shown in Figure 2-13. 
The YVAA mutation led to the significant up-regulation of integrins α2β1, α3β1, and 
α5β1 at the surface of PC3 cells, compared to the CD82 WT transfectant cells,        
Figure 2-13A. The cell surface level of integrin α6β1 did not exhibit a significant change 
in PC3 transfectants.  
 
However, the mutation of the YXXΦ motif of CD82 did not significantly alter the 
cell surface expression of CD82-assocaited tetraspanins such as CD9, CD63, CD81, and 
CD151, Figure 2-13B, indicating that CD82 YXXΦ motif or CD82 trafficking 
determined by this motif is not required for the cell surface expression of these 
tetraspanins in PC3 cells. 
 
The mean fluorescent intensity of these proteins in the PC3-CD82WT and      
PC3-CD82YVAA transfectants, presented in Figure 2-13, were normalized by the 
intensity of the corresponding proteins in the MOCK cells.  
 
 
2.3.9 The mutation of CD82 YXXΦ motif alters the trafficking of integrins α3β1, 
α6β1, and α5β1 into CD82-positive compartments 
   
We then analyzed the role of the CD82 YXXΦ motif in the trafficking of these 
integrins. By examining the internalization of integrins into the intracellular vesicular 
compartments, we determined the effect of CD82 YVAA mutation on integrin 
endocytosis. By examining the colocalization of internalized integrins with CD82 in the 
intracellular vesicular compartments, I determined how much of the integrin traffics into 
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Figure 2-13. Mutation of the YXXΦ motif of CD82 does not affect the cell surface 
expression of CD82-associated tetraspanins but up-regulates the cell surface levels 
of integrins α2, α3, and α5 in PC3 cells. For flow cytometry, confluent cells were 
detached, washed with 1xPBS, and blocked with 2% goat serum on ice for 1 hour to 
block the non-specific binding. A, cells were incubated with 1µg/ml of primary mAb 
such as integrin α2 mAb IIE10, integrin α3 mAb A3X8, α5 mAb BIIG2, integrin α6 
A6BB on ice for 1 hour followed by PBS washes. The cells were then labeled with 
appropriate flurochrome-conjugated secondary Ab on ice for 30 mins followed by 
extensive PBS washes. Cell surface expression of the proteins was analyzed using a 
FACS Calibur flow cyotmeter (BD Biosciences). B, cells were incubated with 1µg/ml 
of primary mAb such as tetraspanins mAbs CD63, CD81, CD151, and CD9 on ice for 1 
hour followed by PBS washes. The cells were then labeled with appropriate 
flurochrome-conjugated secondary Ab on ice for 30 mins followed by extensive PBS 
washes. Cell surface expression of the proteins was analyzed using a FACS Calibur 
flow cyotmeter (BD Biosciences). The histograms represent the mean and standard 
deviation of at least three independent experiments. 
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 CD82-positive compartments after endocytosis. 
 
Upon the mutation of the YXXΦ motif of CD82, the number of integrin        
α2β1-positive vesicles per cell as well as the colocalization of integrin α2β1 with CD82 
was not altered in PC3 transfectant cells, as shown in Figure 2-14A. The average number 
of integrin α2β1-positive vesicles per cell, following integrin α2β1 internalization, was 
18, 16, and 21 for the MOCK, CD82 WT, and CD82 YVAA transfectant cells, 
respectively, Figure 2-14B, left panel, suggesting that the YVAA mutation has no impact 
on integrin α2β1 endocytosis. Furthermore, the colocalization of internalized integrin 
α2β1 with CD82 was unaffected by the mutation of CD82 YXXΦ motif, Figure 2-14B, 
right panel, suggesting that the YVAA mutation has no impact on integrin α2β1 
trafficking into CD82-positive compartment. 
 
The mutation of the YXXΦ motif led to an increase in the number of integrin 
α3β1-positive vesicles per cell, as shown in Figure 2-15A. Visual counting revealed that 
the PC3-MOCK and PC3-CD82 YVAA transfectants contained significantly more 
integrin α3β1-positive vesicles compared to the PC3-CD82 WT transfectants, as shown 
in the left panel of Figure 2-15B. There was not a significant difference in the number of 
the vesicles per cell between the PC3-MOCK and PC3-CD82 YVAA transfectants. These 
data suggest that CD82 inhibits the endocytosis of integrin α3β1 while the YVAA 
mutation disrupted this inhibition. As presented in the right panel of Figure 2-15B, we 
also analyzed the CD82-colocalized, internalized integrin α3β. The quantification using 
LSM software revealed that the integrin α3β1-positive vesicles within the PC3-CD82 WT 
and -CD82 YVAA transfectants were partially colocalized with the CD82-positive 
compartments.  Compared to the CD82 WT cells, we found that significantly more 
internalized integrin α3β1 proteins were colocalized with CD82 proteins in the CD82 
YVAA cells.    
 
In contrast to integrin α2β1, the mutation of CD82 YXXΦ motif led to an 
accumulation of integrin α5β1-positive vesicles inside PC3 cells, compared to the MOCK 
and CD82WT cells, as shown in Figure 2-16A. On the average, only 8 integrin         
α5β1-vesicles per cell were found in the MOCK transfectants, 7 were found in the 
CD82WT transfectants, whereas 23 were found in the CD82 YVAA transfectants, Figure 
2-16B, left panel. Not surprisingly, significantly more integrin α5β1 proteins were 
localized into the CD82-positive compartments, Figure 2-16B. Approximately 17% of 
the internalized integrin α5β1 proteins were colocalized with CD82 proteins in PC3-
CD82 WT cells whereas 50% colocalized with CD82 in PC3-CD82 YVAA cells, 
suggesting that either increased endocytosis or decreased recycling of integrin α5β1 
resulted from CD82 YVAA mutation.         
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Figure 2-14. Mutation of the YXXΦ motif of CD82 does not affect the number of 
vesicles per cell or the colocalization of α2 with CD82 after internalization. A, the 
PC3-Mock, -CD82 WT, and -CD82 YVAA transfectant cells were plated onto glass 
coverslips and grown overnight in complete media. The cells were incubated with 
integrins α2 at 4°C for 1 h. The cells were then allowed to internalize the bound mAb 
by the incubation at 37°C for 1 h, followed by acid washes to remove un-internalized 
mAbs. The cells were fixed, permeablized, and incubated with Alexa 594-conjugated 
2nd mAb. The cells were then labeled with an Alexa 488 conjugated CD82 mAb and 
analyzed using a confocal microscope. B, the number of α2 positive vesicles were 
visually counted, left panel, and the quantifications of α2 colocalization with CD82 
were carried out using LSM image software (right panel). The histograms represent the 
mean and standard deviation from a total of 50 cells in three independent experiments. 
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Figure 2-15. Mutation of the YXXΦ motif of CD82 leads to an accumulation of α3 
vesicles after internalization. A, the PC3-Mock, -CD82 WT, and -CD82 YVAA 
transfectant cells were plated onto glass coverslips and grown overnight in complete 
media. The cells were incubated with integrins α3 at 4°C for 1 h. The cells were then 
allowed to internalize the bound mAb by the incubation at 37°C for 1 h, followed by acid 
washes to remove un-internalized mAbs. The cells were fixed, permeablized, and 
incubated with Alexa 594-conjugated 2nd mAb. The cells were then labeled with an 
Alexa 488 conjugated CD82 mAb and analyzed using a confocal microscope. B, The 
number of α3 positive vesicles were visually counted, left panel, and the quantifications 
of α3 colocalization with CD82 were carried out using LSM image software (right 
panel). The histograms represent the mean and standard deviation from a total of 50 cells 
in three independent experiments. 
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Figure 2-16. Mutation of the YXXΦ motif of CD82 leads to an accumulation of α5 
vesicles after internalization. A, the PC3-MOCK, -CD82 WT, and -CD82 YVAA 
transfectant cells were plated onto glass coverslips and grown overnight in complete 
media. The cells were incubated with integrin α5 at 4°C for 1 h. The cells were then 
allowed to internalize the bound mAb by the incubation at 37°C for 1 h, followed by 
acid washes to remove un-internalized mAbs. The cells were fixed, permeablized, and 
incubated with Alexa 594-conjugated 2nd mAb. The cells were then labeled with an 
Alexa 488 conjugated CD82 mAb and analyzed using a confocal microscope. B, The 
number of α5 positive vesicles were visually counted, left panel, and the quantifications 
of α5 colocalization with CD82 were carried out using LSM image software (right 
panel). The histograms represent the mean and standard deviation from a total of 50 
cells in three independent experiments. 
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 The mutation of CD82 YXXΦ motif did not markedly alter the number of integrin 
α6-positive vesicles per cell after the 1 h endocytosis of integrin α6 in PC3 cells, as  
shown in Figure 2-17A. Roughly, 18, 15, and 14 integrin α6-vesicles per cell can be 
found in the MOCK, CD82WT, and CD82YVAA transfectants, respectively, Figure  
2-17B, left panel. However, the mutation of CD82 YXXΦ motif led to the increased 
internalization of integrin α6 into CD82-positive vesicles, as shown in the right panel of 
Figure 2-17B. Approximately 33% of the internalized integrin α6 proteins were localized 
into CD82-positive compartments in the CD82 YVAA transfectant cells compared to 
22% in the CD82 WT transfectant cells. 
 
 
2.4 SUMMARY 
 
In order to investigate 1) the role of the YXXΦ motif in CD82 trafficking and 2) 
the role of the intracellular trafficking in the motility-suppressive function of CD82, we 
mutated the tyrosine-based trafficking motif of CD82 and generated CD82 YVAA 
mutant. We generated the stable transfectants of MOCK, CD82 WT, and CD82 YVAA 
mutant in PC3 and Du145 cells. Similar levels of CD82 expression were reached in the 
CD82 WT and CD82 YVAA transfectants. We analyzed the steady state localization, 
internalization, and recycling of CD82 to determine the role of the YXXΦ motif in CD82 
trafficking. We found that the YXXΦ motif of CD82 does not play a role in the 
internalization but is responsible for directing the intracellular trafficking, summarized in 
Table 2-1, and the recycling of CD82 back to the plasma membrane. We also found that 
CD82 can be released to the extracellular environment by exosomes and the YXXΦ motif 
of CD82 regulates the exosomal release of CD82.  After being released to the 
extracellular space, CD82 has the potential to elicit its function on neighboring cells.   
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Figure 2-17. Mutation of the YXXΦ motif of CD82 leads to an increase in CD82/α6 
colocalization after internalization. A, the PC3-MOCK, -CD82 WT, and -CD82 
YVAA transfectant cells were plated onto glass coverslips and grown overnight in 
complete media. The cells were incubated with integrins α6 at 4°C for 1 h. The cells 
were then allowed to internalize the bound mAb by the incubation at 37°C for 1 h, 
followed by acid washes to remove un-internalized mAbs. The cells were fixed, 
permeablized, and incubated with Alexa 594-conjugated 2nd mAb. The cells were then 
labeled with an Alexa 488 conjugated CD82 mAb and analyzed using a confocal 
microscope. B, The number of α6 positive vesicles were visually counted, left panel, and 
the quantifications of α6 colocalization with CD82 were carried out using LSM image 
software (right panel). The histograms represent the mean and standard deviation from a 
total of 50 cells in three independent experiments. 
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Percent of colocalization with: CD82 WT CD82 YVAA 
Early Endosomes   
EEA1 41 24.5 
Late Endosomes   
CD63 26 26 
LBPA 32 35 
Lysosomes   
Lysotracker 12 35 
 
Table 2-1. The percentage of CD82 colocalization with intracellular organelle 
markers. 
Table 2-1 summarizes the quantitative data from the colocalization studies found in 
Chapter 2.  
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CHAPTER 3.    THE YXXΦ MOTIF-MEDIATED REGULATION OF THE 
INTRACELLULAR TRAFFICKING OF CD82 
  
 
3.1 INTRODUCTION 
 
Cell migration is a highly integrated, multi-step, locomotive cellular process, 
which orchestrates cellular morphogenesis, contributes to tissue repair, and drives disease 
progression. Understanding the role of cell migration in cancer progression is of the 
utmost importance. De-regulation of cell migration can result in cancer metastasis, which 
is responsible for 90% of cancer-related deaths. Cancer cell migration is typically 
regulated by growth factors, chemokines, matrix-degrading enzymes, and cell-cell and 
cell-matrix adhesion molecules. Earlier studies from our lab and elsewhere revealed that 
CD82 inhibits cell movement by down-regulating the signaling initiated from growth 
factor receptors and integrins and attenuating integrin-dependent cell-matrix adhesion 
(Richardson 2011).    
 
In epithelial cells, cell-cell adhesion is most commonly regulated by cadherin, a 
family of calcium dependent cell-cell adhesion proteins. Cell-cell adhesion can also be 
mediated via calcium-independent cell-cell adhesion molecules such as members of Ig 
Superfamily (IgSF) proteins. Whether cell-cell adhesion contributes to the ability of 
CD82 to inhibit cancer metastasis is not clear. Mechanistically, it is possible that CD82 
suppresses cancer metastasis by increasing cell-cell adhesion in a calcium-dependent 
and/or -independent manner.   
 
Because we observed decreases in recycling and exosomal secretion of CD82 
proteins upon the mutation of CD82 YXXΦ motif, we analyzed the ability of the CD82 
YVAA mutant to move in cell migration and invasion experiments, there by determining 
whether this mutant can still maintain the cell motility-suppressive function of CD82 wild 
type.  Because CD82 may suppress cancer metastasis by increasing cell-cell adhesion in 
both calcium-dependent and/or-independent manners, we also investigated the effect of 
aberrant intracellular trafficking of CD82 on cadherin-dependent and -independent      
cell-cell adhesion.   
 
 
3.2 MATERIALS AND METHODS 
 
 
3.2.1 Materials 
 
The experimental materials used in cell migration and cell-cell adhesion assays 
include Transwell inserts (Falcon), laminin 111 (Invitrogen), Matrigel (BD Biosciences), 
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EDTA (Fisher), ultracentrifuge tubes (Beckman), CD82 mAb TS82b  (kindly provided 
by Dr. Eric Rubenstein of INSERM, France), Transferrin receptor mAb (Molecular 
Probes), flotillin-1 mAb (BD Transduction Laboratories), Diff-Quik staining kit (Baxter 
Merz and Dade Behring), CD81 mAb (Abnova), fibronectin (Gibco), EpCAM mAb 
(Abcam), DMEM (Gibco/Life Technology), Bovine Serum Albumin (Sigma), Fetal 
Bovine Serum (FBS) (Gibco/Life Technology), and Penicillin and Streptomycin 
(Gibco/Life Technology). 
 
 
3.2.2 Cell motility assays 
 
Transwell cell migration assay was performed as previously described (Liu et al 
2007). Briefly, the transfectant cells were detached with 0.25%trypsin-EDTA, washed 
once with PBS, and re-plated onto the Transwell inserts with 8-µm pores, which were 
placed transwell chambers. The underside of the inserts was pre-coated with either 
fibronectin (10µg/ml) or laminin 111 (10 µg/ml) at 4°C overnight and then blocked with 
heat inactivated bovine serum albumin at 37°for 45 min. Fifty thousand cells suspended 
in 500 µl of 0.1% heat-inactivated BSA/DMEM were plated onto each insert Five µl of 
1% FBS/DMEM were added to the lower wells of the insert.  
 
After incubation at 37° for 3 hrs, the cells that had not migrated through the 
inserts were removed with cotton swabs and the cells that had migrated to the undersides 
of the inserts were fixed and stained with Diff-Quick staining kit and counted. Data from 
independent experiments were pooled and analyzed using a two-tailed student’s t-test.  
 
For wound healing assay, the transfectant cells were cultured in 6- or 24-well 
plates. After the cells formed confluent monolayers, cells were treated with 7.5 µg/ml, 
wounds were created by scratching the monolayer with sterile p-200 pipette tips. The 
cells were extensively washed with PBS to remove detached cells and the wounded 
monolayers were replenished with complete DMEM. Wound closure was analyzed using 
an inverted light microscope at indicated time points. Wound closure or “healing” was 
quantitated by measuring the width of the wound at different time points and compared 
between the transfectants statistically. 
 
For invasion assay, briefly, 1x106 cells were added to a Transwell insert, which 
had been  coated with Matrigel, in DMEM containing 1% FBS. The lower wells were 
loaded with complete DMEM. The cells were incubated at 37° for 24 hrs. The cells that 
did not invade into Matrigel were discarded while the cells that invaded through Matrigel 
onto the lower side of the inserts were stained using Diff-Quick solution. The number of 
the cells that invaded through Matrigel was counted under a light microscope, and the 
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results from three independent experiments were quantitated and analyzed using the   
two-tailed Student’s t-test.   
 
 
3.2.3 Hanging drop aggregation assay 
 
The transfectant cells were detached and counted. One thousand cells were 
resuspended in 30μl of complete or calcium-depleted media, and the single cell 
suspensions were plated on the inner surface of the lid of a 24-well plate. Each well was 
filled with PBS, and the lid of the plate was reverted and then placed on the 24-well plate.  
 
The cells were allowed to aggregate, in the hang-drop suspension, over night. 
After aggregation, the cells were passed through a p-200 tip at least 20 times under 
mechanical pressure. The cells were photographed under a light microscope and 
quantified for the numbers of single cells and aggregated cells by manual counting 
Results are displayed as the ratio of the number of aggregated cells to the number of total 
cells. The area of aggregates was measured by ImageJ software.  
 
 
3.2.4 Cell surface expression  
 
For flow cytometry, confluent PC3 cells were detached, washed with 1xPBS, and 
blocked for non-specific binding antibody with 2% goat serum on ice for 1 hour. Cells 
were incubated with 1µg/ml of primary mAb for EpCAM, β1(TS2/16), or IgG2B for 1 
hour followed by PBS washes. The cells were labeled with the appropriate               
FITC-conjugated secondary antibody for 30 minutes followed by extensive PBS washes. 
Cell surface expression of the proteins was analyzed using a FACS Calibur flow 
cyotmeter (BD Biosciences). 
 
 
3.2.5 Transmission electron microscopy 
 
For transmission electron microscopic analysis, the transfectant cells were 
detached, counted, and seeded at a density of 3x104 in transwell inserts. After being 
cultured in complete media, the cells were fixed with 2.5% gluteraldehyde in sodium 
cacodylate buffer. The cells together with insert membrane was then cut into thin sections 
and stained with 0.3% potassium ferrocynide in 2.0% osmium tetroxide and 4.0% uranyl 
acetate. The cells were then examined under a transmission electron microscope, and the 
images were acquired with a digital camera. 
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3.3 RESULTS 
 
 
3.3.1 The mutation of the YXXΦ motif does not abolish CD82-mediated inhibition 
of solitary cell migration 
 
The mutations of the YXXΦ motifs in several transmembrane proteins lead to the 
defects in protein function and often to disease (Cherqui et al 2001; Shrimpton et al 1997) 
However, the mutation of the YXXΦ motif in CD82 did not affect the                       
motility-suppressive function of CD82 in haptotactic and chemotactic Transwell cell 
migration assays, as shown in Figure 3-1. Because cells move in an isolated manner in 
Transwell migration assay, this type of cell migration is considered as solitary cell 
migration. Cell migration onto either laminin 111 or fibronectin or in complete medium 
was increased in PC3-CD82 YVAA transfectants. Both migrations of CD82 WT and 
YVAA cells were inhibited at 3-hour and 24-hour migration time-frame, compared to 
that of Mock cells. 
 
 
3.3.2 The mutation of the YXXΦ motif abolished the motility-suppressive function 
of CD82 in collective cell migration 
 
We analyzed cell migration using wound healing assay and found that the 
mutation of the YXXΦ motif of CD82 abolished the motility-suppressive function of 
CD82 in PC3 transfectant cells, as shown in Figure 3-2, and also in Du145 transfectant 
cells, as shown in Figure 3-3. Upon the mutation of the YXXΦ motif, the transfectant 
cells were able to heal the wound at a significantly faster rate than the CD82 WT 
transfectant did. These results suggest that cell-cell adhesion and/or contact may be 
important for the maintenance of CD82 motility-suppressive function. 
 
Due to the increased cell migration observed in the wound healing experiments, 
we analyzed the invasive potential of the CD82 YVAA transfectant in comparison to the 
Mock and CD82 WT transfectants to invade through Matrigel, a mixture of extracellular 
matrices resembling the basement membrane. The results from the invasion assay reveal 
that the invasive potential of the CD82 YVAA mutant transfectant has been significantly 
increased, as shown in Figure 3-4, compared to the CD82 WT transfectant, and reached 
the level of Mock transfectant. It has been reported that CD82 inhibits the invasive 
potential of cells by increasing the level of tissue inhibitor of metalloproteinase (TIMP), 
therefore decreasing the levels of matrix metalloproteinanses (MMPs), subsequently 
resulting in less degradation of the extracellular matrix, and ultimately suppressing cancer 
metastasis. Because the proteolysis of the extracellular matrix environment determines 
cell invasiveness, the restored invasive ability upon the YVAA mutation suggests that 
CD82 inhibits tumor cell invasiveness by altering the production and/or activity of TIMP 
and MMP.  These migration and invasion data, taken together, suggest that the alteration  
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 Figure 3-1. Mutation of the YXXФ motif does not disrupt CD82-mediated 
inhibition of solitary cell movement. The migration of PC3-MOCK, -CD82 WT and  
-CD82 YVAA transfectant cells was measured by Transwell cell migration assay. Cells 
were detached, washed with PBS, and seeded at a density of 3.3x103 in Transwell 
insert/filter with 8-μm pores. The underside of the insert was precoated with laminin 111 
or fibronectin at the concentration of 10 μg/ml at 4°C overnight and blocked with 0.1% 
heat-inactivated bovine serum albumin at 37°C for 30 min. The cells were allowed to 
migrate for 3 hours (top panel) or 24 hours (bottom panel) at 37°C in 5% CO2. The cells 
that did not migrate through the insert were removed, and the cells that did migrate 
through were fixed and stained with Diff-Quick staining kit.  
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Figure 3-2. The mutation of the YXXФ motif causes a loss of CD82-mediated 
inhibition in collective cell migration in PC3 cells. The PC3-MOCK, -CD82 WT 
and -CD82 YVAA transfectant cells were detached, seeded at a density of 1x106 in 
cell culture dishes, and grown to confluency. After the cells formed monolayers, they 
were treated with 7.5 μg/ml of mitomycin C to prevent cell growth. The wounds were 
created by scraping the confluent monolayer with a p-200 μl tip. A, The images of 
freshly created and healed wounds were captured by using a light microscope 
attached with a digital camera. B, The wound healing process was quantified at 
different time point, and the results are depicted as the amount of cell migration over 
time. 
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Figure 3-3. The mutation of the YXXФ motif causes a loss of CD82-mediated 
inhibition in collective cell migration in Du145 cells. The Du145-MOCK, -CD82 
WT and -CD82 YVAA transfectant cells were detached, seeded at a density of 1x106 
in cell culture dishes, and grown to confluence. After the cells formed monolayers, 
they were treated with 10 μg/ml of mitomycin C to prevent cell growth. The wounds 
were created by scraping the confluent monolayer with a p-200 μl tip. A, The images 
of freshly created and healed wounds were captured by using a light microscope 
attached with a digital camera. B, The wound healing process was quantified at 
different time point, and the results are depicted as the amount of cell migration over 
time. 
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Figure 3-4. The mutation of the YXXΦ motif of CD82 attenuates CD82-mediated 
inhibition of cell invasion. The PC3-MOCK, -CD82 WT and -CD82 YVAA 
transfectant cells were added to the Transwell inserts, previously coated with Matrigel, 
in DMEM containing 1% FBS. The lower wells of the insert were loaded with 
complete DMEM. The cells were incubated at 37° for 24 hrs. The cells that did not 
invade through Matrigel were removed, and the cell that invaded through Matrigel onto 
the lower side of the Transwell inserts were stained using Diff-Quick solution. The 
number of the cells invaded through Matrigel was counted using a light microscope, 
and the results from three independent experiments were analyzed statistically using the 
student’s t-test.   
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in the intracellular trafficking of CD82, upon mutation of the YXXΦ motif, leads to the 
loss of CD82-mediated suppressive function in collective migration and invasiveness. 
 
 
3.3.3 The mutation of the YXXΦ motif of CD82 leads to an increase in CD82 
mediated cell-cell adhesion 
 
The over-expression of CD82 leads to an increase in cell-cell adhesion (Jee at al 
2008) and has been proposed as one of the mechanisms that CD82 uses to elicit its 
motility-suppressive function. The wound healing process is regulated not only by cell 
motility but also by cell-cell adhesion. Since we observed an increase in the wound 
healing of the CD82 YVAA mutant, we predicted that CD82 YVAA mutant would 
exhibit an alteration in cell-cell adhesion compared to CD82 WT. Therefore, we 
compared the strength of calcium-dependent and -independent cell-cell adhesion between 
the Mock, CD82 WT, and CD82 YVAA transfectants using a hanging drop cell 
aggregation assay, a well-established method to assess cell-cell adhesiveness.  
 
We evaluated the strength of cell-cell adhesion by quantifying the size of cell 
aggregates and the number of aggregated cells, as presented in Figure 3-5. To our 
surprise, the overexpression of CD82 in PC3 cells reduced the level of total cell-cell 
adhesion, i.e., the sum of calcium-dependent and -independent cell-cell adhesion, after 
exposure to the stress of shear force. The YVAA mutation attenuated this reduction. We 
even observed an increase in cell-cell adhesion in PC3-CD82 YVAA transfectant 
compared to PC3-MOCK transfectant if cell-cell adhesion is quantified as the area of 
aggregates (see the following paragraph).  
 
We then quantified the difference in total cell-cell adhesion. The histograms in 
Figure 3-6A represents the quantitative data depicted as the ratio of the number of 
aggregated cells divided by the total number of cells. After being exposed to shear stress, 
90% of Mock and 94% of CD82 YVAA transfectant cells remained aggregated together 
whereas only 74% of CD82 WT cells remained aggregated. In Figure 3-6B, the areas of 
cell aggregates were analyzed by ImageJ software, and the quantification revealed that 
the average area of each of the CD82 YVAA transfectant aggregate is roughly 25,000 
pixels whereas MOCK and CD82 WT trasnfectant aggregate averages roughly 19,000 
and 16,500 pixels, respectively. These results indicate that the mutation in the YXXΦ 
motif of CD82 restored the reduction in total cell-cell adhesion and may even lead to an 
increase in cell-cell adhesion compared to Mock cells.  
 
  To further explore the mechanism governing CD82-mediated inhibition of       
cell-cell adhesion, we determined the role of calcium in cell-cell adhesion by removing  
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Figure 3-5. The YXXΦ mutation attenuates CD82-mediated inhibition of total    
cell-cell aggregation in PC3 cells. For hanging drop aggregation assay, the              
PC3-MOCK, -CD82 WT and -CD82 YVAA transfectant cells were detached, 
resuspended at a density of 2.5x103 in 30 μl of complete media, seeded on the underside 
of a 24-well plate lid, and allowed to aggregate for 24 hours at 37°C in 5% CO2. 
Aggregated cells were subjected to the shear flow by passing through a 200-μl 
pipetteman tip twenty times. The cell aggregates prior to and after shear stress were 
photographed using a light microscope attached with a digital camera.  
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Figure 3-6. Mutation of the YXXΦ motif of CD82 attenuates CD82-mediated 
inhibition of total cell-cell aggregation in PC3 cells. The total cell-cell adhesion of the 
PC3-MOCK, -CD82 WT and -CD82 YVAA transfectant cells were examined in the 
hanging drop aggregation assay in complete media as described in Figure 3-5. A, the 
cell aggregates were quantitated by visually counting the number of aggregated cells 
and dividing the number of aggregated cells by the number of total input cells. The 
results are displayed as the percentage of aggregated cells from the total number of cells. 
B, the surface areas of cell aggregates were quantitated by ImageJ software, and the 
results are displayed as area of aggregated cells.  
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calcium from the medium. We observed, as shown in Figure 3-7, that the difference in 
cell-cell aggregation between CD82 WT and YVAA transfectants was significantly 
diminished after shear stress. In Figure 3-7, it was observed that, after shear stress, the 
aggregates from the PC3-YVAA transfectant were smaller and not tightly aggregated 
when compared to the aggregates formed in the calcium-dependent aggregation 
experiment. Moreover, after shear stress, the PC3-YVAA transfectant cells exhibited 
much more single cells compared to the PC3-Mock and -CD82 WT transfectants in the 
calcium-independent aggregation experiment. 
 
We then quantified the difference in calcium-independent cell-cell adhesion. The 
histograms in Figure 3-8A represents the ratio of the number of aggregated cells divided 
by the number of single cells. We found that there is not a statistically significant 
difference in terms of the percentage of aggregated cells between PC3-CD82 YVAA and 
PC3-CD82 WT transfectant cells. Approximately 63% of CD82 YVAA mutant cells and 
72% of CD82 WT cells remained aggregated after exposure to shear force. The data in 
Figure 3-8B represents the area of aggregated cells analyzed by image J software and 
reveals a statically significant difference in the average size of aggregates between the 
transfectants upon removal of calcium. The average area of each of the CD82 YVAA 
transfectant aggregate is roughly 12,000 pixels whereas CD82 WT trasnfectant aggregate 
averages roughly 15,000 pixels and MOCK 21,500. These data indicate that the increased 
total cell-cell adhesion of CD82 YVAA transfectant is largely calcium dependent.   
 
We also analyzed the cell-cell adhesion in the Du145 transfectants. In contrast to 
the PC3 transfectants, CD82 overexpression enhanced total cell-cell adhesion in Du145 
cells, Figure 3-9A. Similar to the result obtained from PC3 transfectants, CD82 
overexpression did not alter the total calcium-independent cell-cell adhesion in Du145 
cells, Figure 3-9B. Interestingly, the YVAA mutation markedly increased total cell-cell 
adhesion in Du145 cells compared to both Mock and CD82-WT transfectant cells, 
Figure 3-9C, which is consistent with the results from PC3 transfectant cells. But, unlike 
the effect on PC3 transfectants, the YVAA mutation also markedly increased           
calcium-independent cell-cell adhesion in Du145 cells.       
 
We also measured the cell surface level of a cell adhesion molecule that is 
associated with cancer metastasis, EpCAM. As shown in Figure 3-10, we found that, 
upon mutation of the YXXΦ motif of CD82, there is a significant increase in the cell 
surface levels of EpCAM in the CD82 YVAA mutant compared to the Mock and CD82 
WT transfectants. These results suggest that the inefficiency of CD82 YVAA mutant to 
traffic back to the plasma membrane and be released to the surroundings via exosomes 
leads to an increase in the expression at the cell surface of cell-cell adhesion proteins, 
which is normally suppressed by CD82. 
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Figure 3-7. The YXXΦ mutation does not affect calcium-independent cell-cell 
aggregation in PC3 cells. For hanging drop aggregation assay, the PC3-MOCK,        
-CD82 WT and -CD82 YVAA transfectant cells were detached, resuspended in 30 μl 
of calcium-free medium at a density of 2.5x103, seeded on the underside of a 24-well 
plate lid, and allowed to aggregate for 24 h at 37°C in 5% CO2. Aggregated cells were 
subjected to the shear stress by passage through a 200-μl pipetteman tip twenty times. 
The cell aggregates prior to and after shear stress were photographed using a light 
microscope attached with a digital camera.   
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Figure 3-8. The YXXΦ mutation decreases calcium-independent cell-cell 
aggregation in PC3 cells. The total cell-cell adhesion of the PC3-MOCK, -CD82 
WT and -CD82 YVAA transfectant cells were examined in the hanging drop 
aggregation assay in calcium-free media as described in Figure 3-5. A, The cell 
aggregates were quantitated by visually counting the number of aggregated cells and 
dividing by the total, input, cell number. The results are displayed as the percentage 
of aggregated cells divided by the total number of cells. B The surface areas of cell 
aggregates were quantitated by ImageJ software, and the results are displayed as area 
of aggregated cells.  
 
A 
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Figure 3-9. The effects of CD82 overexpression and CD82 YVAA mutation on 
cell-cell aggregation in Du145 cells. For hanging drop aggregation assay, the 
Du145-MOCK, -CD82 WT and -CD82 YVAA transfectant cells were detached, 
resuspended at a density of 2.5x103 in 30 μl of meida, seeded on the underside of a 
24-well plate lid, and allowed to aggregate for 24 hours at 37°C in 5% CO2. 
Aggregated cells were subjected to the shear stress by passage through a 200-μl 
pipetteman tip twenty times. The cell aggregates prior to and after shear stress were 
photographed using a light microscope attached with a digital camera. A, The 
hanging drop aggregation assay was performed in complete media. B, The hanging 
drop aggregation assay was performed in calcium-free media. C, The surface areas of 
cell aggregates were quantitated by ImageJ software, and the results are displayed as 
area of aggregated cells.  
 
 
 
 
 A B 
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Figure 3-10. The mutation of the YXXΦ motif of CD82 leads to an increase in 
the cell surface expression of the cell adhesion molecule EpCAM. For flow 
cytometry, confluent PC3 transfectant cells were detached, washed with 1xPBS, and 
blocked with 2% goat serum on ice for 1 hour to block non-specific binding. The cells 
were incubated with 1µg/ml of primary mAbs, which include murine IgG2b as 
negative control, β1 integrin mAb TS2/16 as positive control, and EpCAM mAb, at 
4oC for 1 hour followed by PBS washes. The cells were labeled with FITC 
conjugated, goat-anti-mouse secondary Ab for 30 min followed by extensive PBS 
washes. The cell surface expression of the proteins was analyzed using a FACS 
Calibur flow cyotmeter (BD Biosciences). 
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3.3.4 CD82 YVAA transfectants probably increase desmosome-mediated cell-cell 
adhesion 
 
 Epithelial cell-cell adhesion is responsible for forming and maintaining the  
structural integrity of organs and tissues. To further determine the mechanism by which 
CD82 trafficking regulates cell-cell adhesion; we used transmission electron microscopy 
to investigate the cell-cell junctions in PC3 transfectants, Figure 3-11. Under the electron 
microscope, we frequently observed multiple, long, electron-dense cell-cell junctions in 
PC3-Mock and PC3-CD82 YVAA transfectant cells, Figure 3-11, while the PC3-CD82 
WT transfectant cells usually exhibited fewer, shorter, and less electron-dense cell-cell 
junctions, as shown in Figure 3-11.  
 
The results presented in Figure 3-11A also revealed that the cell-cell junctional 
structures resemble desmosomes, as indicated by arrows. The length and frequency per 
cell of desmosomes were analyzed by Image J and visual counting, respectively, and the 
data are presented in Figure 3-11B and 3-11C. There was an average of 1.7 and 1.5 
desmosomes per cell in the MOCK and CD82 YVAA transfectants, respectively, and 
0.63 per cell in the CD82 WT transfectants. The Mock and YVAA transfectants exhibited 
more than a 2 fold increase in the number of desmosomes per cell compared to the CD82 
WT transfectant. We also examined the length of desmosomes in these three transfectant, 
Figure 3-11C, and we found that the average length of desmosomes was 0.45, 0.37, and 
0.16 arbitrary units for the CD82 YVAA, MOCK, and WT transfectants, respectively.  
Together, these data suggest that desmosomes likely take part in the loss of inhibition in 
calcium-dependent cell-cell adhesion in CD82-YVAA mutant cells and the inhibition in 
calcium-dependent cell-cell adhesion in CD82 WT cells.   
   
     
3.4 SUMMARY  
 
In this chapter, we focused on the role that the YXXΦ motif plays in CD82 
motility suppressing function. We observed that the mutation of the YXXΦ motif of 
CD82 leads to the loss of inhibitory activities in collective cell migration and invasion but 
has no effect on solitary cell migration. These observations imply that CD82 regulates 
cell movement through modulating, at least partially, cell-cell adhesion.  
 
We also observed an increase in cell-cell adhesion, which appears to be   
cadherin-mediated, when the recycling and/or releasing of CD82 become aberrant. This 
observation implies that the increased cell-cell adhesion in the CD82 YVAA mutant 
plays a key role in collective cell migration and cell invasion.  This result also suggests 
that the increase in cell-cell adhesion does not necessarily impede cell migration in all 
circumstances as previously expected. 
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Figure 3-11. The mutation of the YXXΦ motif in CD82 attenuated              
CD82-dependent reduction in the formation of cell-cell adhesions. For electron 
microscopic analysis, the PC3 transfectant cells were detached, counted, and seeded 
at a density of 3x104 in Transwell inserts. After being cultured to monolayer, the cells 
were fixed with 2.5% gluteraldehyde in sodium cacodylate buffer. The cells together 
with the filter membrane were then into thin sections and stained with 0.3% 
potassium ferrocynide in 2.0% osmium tetroxinde and 4.0% uranyl acetate. A, the 
cells were imaged under a transmission electron microscope connected to a digital 
camera. B, the length of cell-cell contacts per cell was measured using ImageJ 
software, and the results are presented as the average length of desmosome. C, The 
number of desmosomes per cell per section was visually counted, and the data 
represents the average desmosomes per cell per section by dividing the total numbers 
of desmosomes with the total number of cells counted (n=30 cells). 
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CHAPTER 4.    DISCUSSION 
 
 
4.1 INTRODUCTION  
 
For the first time, the biological functions of YXXΦ motif of CD82 have been 
characterized. We found that the YXXΦ motif of CD82 does not play a crucial role in 
endocytosis as the YXXΦ motifs in other transmembrane proteins such as CD63 and 
CD151. In addition, the YXXΦ motif of CD82 is not required for the targeting of CD82 
proteins to the late endosome and/or multivesicular bodies, as evidenced by the 
equivalent amounts of CD82 wild type and YVAA mutant proteins present in these 
vesicular compartments. Our studies revealed  that the YXXΦ motif of CD82 regulates 1) 
the sorting of CD82 proteins to the lysosomal acidic compartment, 2) the recycling of 
CD82 from late endosomes back to the plasma membrane, in a Rab 11-dependent 
manner, and 3) the secreting of CD82 proteins into the extracellular environment, via 
exosomes.  
 
Most notably, the mutation of the YXXΦ motif leads to an abrogation in     
CD82-mediated inhibition of cell motility, specifically collective cell migration and 
invasion. We found that the mutation of the YXXΦ motif also mediates                 
calcium-dependent cell-cell adhesion and leads to the increase in the cell surface 
expressions of metastasis-promoting cell-cell adhesion molecules such as EpCAM and   
I-CAM. Likely, cell-cell adhesion directly contributes to CD82-dependent inhibition of 
cell motility. In other words, CD82 inhibits cell motility by modulating cell-cell adhesion 
and the vesicular trafficking of CD82 is involved in this modulation. 
 
It is well established that CD82 is a tumor metastasis suppressor (Liu and Zhang 
2006; Miranti 2009; Richardson 2011). However, thus far, it still remains unclear how 
CD82 elicits its metastasis-suppressive function in vivo and cell motility-inhibitory 
activity in vitro. There have been several hypotheses proposed to explain how CD82 
suppresses metastasis and inhibits cell motility. These include increased cell-cell 
adhesion, up-regulation of TIMP activity and therefore down-regulation of MMP activity, 
reorganization of the actin cytoskeleton, preventing protrusion and retraction during cell 
migration, and interaction with DARC on endothelial cells (Liu and Zhang 2006; Miranti 
2009; Richardson 2011).  
 
In this study, we focused on the mechanism by which CD82 inhibits cell 
migration and cell invasion, from the vesicular trafficking point of view. It has been 
proposed that CD82 elicits its function indirectly by sequestering other membrane 
proteins into TEMs and regulating their function (Liu and Zhang, 2006; Miranti, 2009; 
Richardson 2011). Also, it is well known that the intracellular trafficking of a protein 
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could regulate its function.  An earlier study from our lab demonstrated that CD82 
undergoes sterol lipid-dependent endocytosis and traffics to late endosomal and 
lysosomal compartments (Xu et al 2009). To our knowledge, there has not been an 
investigation on the role that intracellular trafficking of CD82 plays in its function.  This 
study sets out to analyze: 1) the role of the YXXΦ intracellular trafficking motif in CD82 
trafficking and 2) the role of CD82 intracellular is trafficking in CD82-mediated  
motility-suppressive function. 
 
In the experiments illustrated in Chapter 2, we characterized the role of the 
YXXΦ motif in CD82 trafficking. Based on the results presented in Chapter 3, we 
defined the role of the CD82 YXXΦ motif in the cell motility-suppressive function of 
CD82. Our current understanding is that proper recycling of CD82 back to the plasma 
membrane and/or exosomal release of CD82 to the extracellular environment are likely to 
be important for CD82-mediated inhibition of collective cell migration and invasion. In 
this chapter we will further discuss our findings/understandings in detail and define the 
biological significance of these findings.  
 
 
4.2 THE YXXΦ MOTIF IS NOT ESSENTIAL FOR CD82 INTERNALIZATION 
 
CD82 is widely expressed in epithelial and endothelial cells (Miranti, 2009). It is 
found on the plasma membrane, within late endosomes, lysosomes, and in exosomes 
(Richardson 2011). These observations suggest that CD82 undergoes endocytosis and 
follows a defined intracellular trafficking route. Understanding the importance of CD82 
intracellular trafficking on its function may provide further insight into the mechanism of 
CD82-mediated inhibition of cell motility.  
 
In this study, we investigated the role of the tyrosine-based sorting motif, YXXΦ, 
in the intracellular trafficking and function of CD82. We generated a mutation in the 
YXXΦ motif of CD82, YSKV, by simultaneously replacing the tyrosine and valine 
residues to alanine, yielding ASKA and obtained the YVAA mutant. Compared to the 
CD82 WT transfectant, the CD82 YVAA transfectant expressed a similar level of CD82 
proteins at the cell surface, suggesting that the YXXΦ motif of CD82 is not required for 
the cell surface expression of CD82 proteins. This YVAA mutation neither caused an 
alteration in the steady-state distribution of CD82 proteins within cells nor attenuated the 
internalization of CD82 compared to the CD82 wild type, suggesting that the YXXΦ 
motif of CD82 is not essential for the endocytosis of CD82 proteins.  
 
One of the most noted characteristics of the YXXΦ motif function is to rapidly 
internalize transmembrane proteins and receptors from the plasma membrane (Bonifacino 
and Dell’Angelica 1999; Bonifacino and Traub 2003; Lam-Yuk-Tseung et al 2005;   
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Lam-Yuk-Tseung 2006). Thus, the role of the YXXΦ motif in CD82 is inconsistent with 
the bona fide function of the YXXΦ motif, i.e. driving the internalization of 
transmembrane proteins. For example, the mutation of the tetraspanin CD151 YXXΦ 
motif leads to an accumulation of proteins at the plasma membrane after a 30 to 60 
minute pulse-chase endocytosis (Liu et al 2007). However, we found that the 
colocalization of CD82 proteins with EEA1, a marker of the clathrin-positive early 
endosomes, became reduced upon YVAA mutation (data not shown), suggesting that 
CD82 could be internalized through the clathrin pathway although this pathway is not 
essential for CD82 endocytosis.  This observation also suggests that, upon the YVAA 
mutation, CD82 proteins are driven to the clathrin-independent pathway. Nevertheless, 
the observations made from this study are consistent with our earlier finding, i.e., the 
clathrin-dependent pathway is not required for CD82 endocytosis and CD82 typically 
undergoes clathrin-independent but sterol lipid-dependent endocytosis (Xu et al 2009). 
 
 
4.3 THE MUTATION OF THE CD82 YXXΦ MOTIF LEADS TO THE 
ATTENUATION AND ALTERATION IN CD82 RECYCLING  
 
In addition to the role in internalization, the YXXΦ motif has also been 
implicated in targeting proteins to various intracellular vesicular compartments 
(Bonifacino and Dell’Angelica 1999; Bonifacino and Traub 2003; Cherqui et al 2001; 
Lam-Yuk-Tseung et al 2005; Lam-Yuk-Tseung 2006). We observed that the numbers of 
CD82 YVAA mutant-positive intracellular vesicles were significantly more than those of 
CD82 WT after prolonged internalization, i.e. 3-hour internalization, suggesting that 
CD82 YXXΦ motif regulates the trafficking step(s) after endocytosis. This observation is 
similar to previously published reports in which the mutation or truncation of the            
C-terminal YXXΦ motif leads to an accumulation of vesicles within cells due to a defect 
in recycling (Cherqui  et al 2001; Lam-Yuk-Tseung et al 2005; Lam-Yuk-Tseung et al 
2006). Indeed, another important characteristic of the YXXΦ motif is the delivery of the 
internalized proteins to the recycling endosomes (Bonifacino and Traub 2003). Hence, 
the accumulation of CD82 proteins upon the YVAA mutation could result from 
attenuated recycling.  
 
The recycling data suggests that the function of the YXXΦ motif of CD82 is to 
regulate its intracellular trafficking, specifically recycling. The increase of intracellular 
CD82 YVAA mutant proteins after 3-hour recycling suggests that some of the 
internalized CD82 YVAA mutant proteins may traffic to the acidic vesicular 
compartment and therefore cannot be detected by CD82 mAb, the probe for both 
endocytosis and recycling assays. The CD82 YVAA mutant proteins may gradually 
traffic out of the acidic vesicular compartment after the 3 hour incubation at 37 oC for 
recycling and subsequently become detectable by CD82 mAb. As a result, more CD82 
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staining was found intracellularly in CD82 YVAA transfectant after 3-hour recycling 
than after endocytosis or 1-hour recycling. Nevertheless, the mutation in the YXXΦ motif 
of CD82 appears to redirect CD82 from the recycling back to the plasma membrane.  The 
data presented in Figure 2-7 represents the average numbers or levels of CD82-positive 
intracellular vesicles per cell after 1 and 3 hour recycling. In Figure 2-7A, the quantitated 
data of recycling were obtained from the immunofluorescence images. Figure 2-7B 
represents the mean fluorescent intensity of the CD82 staining that remained intracellular 
after recycling. This data suggests that the function of the YXXΦ motif of CD82 is to 
regulate its intracellular trafficking, specifically recycling. 
 
Proteins that are recycled back to the plasma membrane either follow a “fast” 
internalization and recycling loop in which proteins are typically trafficked back to the 
plasma membrane within minutes, or a “slow” internalization and recycling loop in 
which proteins are trafficked back to the plasma membrane within minutes to hours. The 
Rab4 dependent recycling occurs within minutes and is used primarily by the transferrin 
receptor and some other proteins whereas the Rab11 dependent recycling can occur 
within minutes but primarily occurs within hours.  
 
To determine if the intracellulary accumulated CD82 YVAA mutant-positive 
vesicles resulted from an alteration in the trafficking to the recycling endosomes, we 
traced CD82 during the early stages of trafficking. An earlier study from our lab 
demonstrated that CD82 trafficked more readily to the Rab11-positive compartments 
compared to the Rab4-psotive compartment (Xu et al 2009; our unpublished data). In 
addition, more colocalization was found between CD82 and Rab11 versus the amount of 
co-localization of CD82 and Rab4 at steady state (Xu et al 2009; our unpublished data). It 
was also discovered that, using a dominant-negative Rab11 mutant, CD82 WT proteins 
were accumulated within Rab 11-positive compartments. Thus, CD82 proteins are more 
likely recycled back to the plasma membrane through Rab11 recycling endosome 
pathway. This set of data further corroborates the notion that CD82 recycles slowly. On 
the contrary, neither the distribution, accumulation, nor the colocalization with Rab11 of 
the CD82 YVAA mutant-positive vesicles was affected by the dominant-negative mutant 
of Rab 11 GTPase. It suggests that the mutation of CD82 YXXΦ motif disrupts the                 
Rab11-dependent recycling mechanism of CD82 and therefore leads to an accumulation 
of the CD82 mutant proteins in intracellular vesicles. Hence, the YXXΦ motif of CD82 
in needed for the Rab 11-dependent recycling of CD82. 
 
The reduced recycling of CD82 YVAA mutant back to the plasma membrane and 
the unaltered steady-state distribution of this mutant within cells implicate that the CD82 
YVAA mutant proteins are recycled back to the plasma membrane through other 
recycling mechanism(s) such as Rab4 or Rab25 (Caswell et al 2007). The mechanism 
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responsible for the recycling of CD82 YVAA mutant remains to be determined in future 
studies.     
 
 
4.4 THE MUTATION OF THE CD82 YXXΦ MOTIF DISRUPTS 
INTRACELLULAR TRAFFICKING OF CD82 AND CAUSES THE MUTATED 
CD82 PROTEINS TO ACCUMULATE IN LYSOSOMES  
 
Because CD82 becomes deficient in recycling in the absence of a functional 
tyrosine-based sorting motif, it is likely that the mutated CD82 proteins will be driven to 
other intracellular vesicular compartment(s) such as late endosomes and lysosomes. I 
further analyzed the effect of the mutation of the YXXΦ motif on the trafficking of CD82 
proteins to other endosomal and/or lysosomal compartments. CD82 has been found in 
early endosomes, multi-vesicular bodies/late endosomes as well as exosomes (Escola et 
al 1998; Pelchen-Matthews 2003; Xu et al 2009). These earlier results are consistent with 
the function of the YXXΦ motif in intracellular trafficking; in addition the YXXΦ motif 
was also reported to play a key role in the targeting of proteins to the lysosome for 
degradation 
 
Both CD82 WT and CD82 YVAA transfectants are localized at the late 
endosomes to similar extents, as shown in Table 2-1. However, we found that, in 
comparison to CD82 WT, significantly more CD82 YVAA mutant-positive vesicles 
belong to the lysosomal compartment (Figure 2-10 and Table 2-1). This observation is 
atypical for the YXXΦ motif due to its lysosomal sorting characteristic/function. If the 
YXXΦ motif of CD82 is required for trafficking CD82 to lysosome, the mutation of the 
YXXΦ motif should lead to the accumulation of the CD82 YVAA mutant-positive 
vesicles in other intracellular compartments such as the early or late endosomes and 
result in less accumulation of CD82 in lysosomes. In contrast, more CD82 proteins were 
accumulated in acidic, lysosomal compartments when the YXXΦ motif is mutated. 
Likely, the CD82 YVAA mutant proteins are redirected to lysosome for degradation 
because they cannot be properly recycled back to the plasma membrane in a timely 
fashion (see Section 4. 3). Alternatively, it is also possible that CD82 YVAA mutant 
proteins become structurally or coformationally aberrant and then destined to lysosomes 
for degradation. However, the latter is less likely since CD82 YVAA mutant proteins are 
readily recognized by various CD82 mAbs, can be expressed at the cell surface, still exert 
inhibition on solitary, and are able to associate with other tetraspanins.       
  
A majority of publications have underlined that one of the main functions of the 
YXXΦ motif is to drive the trafficking of the transmembrane proteins to lysosomes for 
degradation (Bonifacino and Dell’Angelica 1999; Bonifacino and Traub 2003; Cherqui et 
al 2001; Lam-Yuk-Tseung et al 2005; Lam-Yuk-Tseung 2006). Those transmembrane 
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proteins examined in the previous studies usually undergo clathrin-dependent 
internalization, which is mediated by adaptor proteins, namely the µ2 subunit of the AP-2 
complex. The AP-2 complex plays a key role in initiating transmembrane protein 
endocytosis, as aforementioned. However, CD82 mainly uses a cholesterol-dependent, 
lipid raft-mediated, and clathrin-/caveolae-independent mechanism for internalization 
(Xu et al 2009). Moreover, the C-terminal cytoplasmic domain of CD82 does not interact 
with the µ2 subunit or the AP-2 complex of the clathrin machinery in yeast two-hybrid 
system (Xu et al 2009). Hence, the YXXΦ motif of CD82 neither determines the 
endocytosis of CD82 nor is needed for trafficking CD82 to lysosomes.  
 
It is highly likely that, upon mutation of the YXXΦ motif, a default lysosomal 
trafficking mechanism becomes active by, recognizing the mutated CD82 protein as a 
protein destined for lysosomal delivery, and traffics CD82 YVAA mutant proteins to the 
lysosome for degradation. Hence, the CD82 mutant still exhibits the unaltered rates of 
internalization and trafficking to the late endosome compared to CD82 WT. Also, it is 
possible that the mutation of CD82 YXXΦ motif causes CD82 proteins to undergo a 
different mechanism of internalization and then subsequently a different mechanism of 
lysosomal targeting. Furthermore, several studies have shown that the heterotetrameric 
adaptor protein (AP) complexes, localized in endosomes, are important for the targeting 
of membrane protein to lysosomes. Although CD82 has been shown to have no 
interaction with the µ2 subunit of the AP-2 adaptor protein (Xu et al 2009), lines of 
evidence indicate that the adaptor proteins AP3 and AP4 rather than the AP2 are 
responsible for lysosomal targeting by binding to the tyrosine-based sorting motif of 
lysosomal proteins (Aguilar et al 2001; Ohno et al 1998). However, our early study also 
demonstrated that the C-terminal cytoplasmic domain of CD82 does not interact with the 
µ3 and µ4 subunits of AP3 and AP4 complexes, respectively, in yeast two-hybrid system 
(Xu et al 2009), consistent with our observation that the YXXΦ motif of CD82 is not 
needed for the lysosomal targeting of CD82. Therefore, further structural-and-functional 
analysis of the CD82 protein is needed to identify the structural element(s) that 
determines the lysosomal targeting of CD82.  
 
 
4.5 THE MUTATION OF THE CD82 YXXΦ REDUCED THE EXOSOMAL 
SECRETION OF CD82 PROTEINS  
 
Interestingly, I also found that significantly less CD82 YVAA proteins were 
released via exosomes compared to the CD82 wild type proteins detected in the exosomal 
preparation. Notably, the formation and secretion of exosomes per se were not altered by 
the CD82 YVAA mutation, evidenced by the facts that the equivalent amounts of 
exosome marker flotillin were found in the exosome preparations from CD82 wild type 
and CD82 YVAA mutant transfectant cells. These observations actually underline that 
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the CD82 YVAA motif facilitates the sorting of CD82 proteins into interluminal vesicles 
(ILVs) in the multivesicular bodies (MVBs). In addition to CD82, fewer tetraspanin 
CD81 proteins were also found in exosomes. Because CD81 and CD82 associate with 
each other, the reduction of CD81 in exosomes probably results from the reduced sorting 
of CD82 into the exosomes. But CD82 YVAA motif is not required for the formation of 
interluminal vesicles in MVBs. 
 
 Although Rab 27 has been reported to play a key role in the release of exosomes, 
Rab 11 GTPase is also associated with exosome release (Hsu et al 2010; Savina et al 
2005). Because unlike CD82 wild type proteins CD82 YVAA mutant proteins appear to 
traffic in a Rab11-independent manner, the CD82 YVAA mutant proteins probably 
cannot be recognized by the exsosomal release mechanism that is regulated by Rab11. As 
a consequence, fewer CD82 YVAA mutant proteins were released by exosomes 
compared to CD82 wild type proteins. Hence, the YXXΦ motif of CD82 may be needed 
for the Rab11-dependent exosomal release of CD82.  
 
Taken together, our studies on the roles of the YXXΦ motif in CD82 trafficking 
demonstrated that the function of the YXXΦ motif of CD82 is not critical at the 
internalization step of the intracellular trafficking cascade, consistent with a previous 
report from our lab, but at the late endosomal trafficking step which subsequently affects 
downstream trafficking, namely the Rab11-mediated recycling step and the exosomal 
formation step.  
 
 
4.6 THE PROPER INTRACELLULAR TRAFFICKING OF CD82 IS NEEDED 
FOR CD82-MEDIATED INHIBITION OF CELL MOTILITY 
 
Based on the hypothesis that the trafficking of CD82 plays an important role in 
the biological function of CD82, we predicted that the CD82 YVAA mutant no longer 
carries the metastasis-suppressive and/or motility-inhibitory activities of CD82 due to the 
decreased recycling back to the plasma membrane and the altered formation of exosomes. 
The released exosomes may serve as a milieu in the extracellular environment to regulate 
cell migration.  
 
The main pathological function of CD82 is to inhibit cell movement and cancer 
metastasis. CD82 has been deemed as a tumor metastasis suppressor due to 1) the loss of 
expression in metastatic tumors and 2) direct suppression of tumor metastasis in animal 
models. Metastasis could result from the de-regulation of cell migration. Cell migration is 
the locomotive process whereby cells move from one location to another. During cell 
migration, subcellular events including polarization, protrusion and adhesion, 
translocation of the cell body, and retraction of the rear are involved. These processes are 
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coordinated, regulated, and integrated by cell adhesion and signaling proteins such as 
integrins, cadherins, and immunoglobulin superfamily (IgSF) proteins. Recent studies 
demonstrated that the trafficking of cell adhesion molecules directly regulate cell 
movement.   
 
As described in Chapter 3, I analyzed the functional consequence of the mutation 
of the YXXΦ motif on CD82-mediated motility-suppressing functions. I first examined 
the effect of this mutation on the cell migration-suppressive function of CD82. For the 
solitary type of cell migration, I observed that the mutation of the YXXΦ motif did not 
affect cell migration compared to CD82 WT. Both CD82 WT and YVAA mutant were 
able to significantly inhibit solitary cell migration when compared MOCK cells. Because 
the YVAA mutation attenuates the recycling and exosomal release of CD82, these results 
suggest that proper recycling and exosomal release of CD82 are not required for CD82-
dependent inhibition of solitary cell migration. Surprisingly and also interestingly, in 
wound healing assays, I observed a significant increase in wound closure in the CD82 
YVAA mutant transfectant compared to that of the CD82 WT transfectant. The rate of 
wound closure of the CD82 YVAA transfectants was almost identical to that of the 
MOCK transfectants. Because cells migrate as cohorts during the wound healing process 
and this assay specifies collective cell migration, these results suggest that the YXXΦ 
motif is needed for CD82-mediated inhibition of collective cell migration.  Because   
cell-cell adhesion is heavily involved in collective migration, this result also implicates 
that the CD82 trafficking steps determined or influenced by its YXXΦ motif could 
regulate cell-cell adhesion.  
 
These results further suggest that 1) vesicular trafficking is involved differentially 
in solitary and collective cell migrations and 2) the subcellular mechanism that cells use 
for solitary migration is quite different from the one that cells use for collective cell 
migration. The  conclusions from these observations include that 1) the migration 
properties for single cell migration are different from collective cell migration, 2) the 
intracellular trafficking of CD82 such as recycling and exosomal release likely regulates 
cell-cell adhesion, and 3) the altered cell-cell adhesion caused by the aberrant CD82 
trafficking likely results in the abolishment of motility-inhibitory activity of CD82.  
 
In both collective and solitary cell movement, the cells must become         
anterior-posterior or front-rear polarized in order to migrate; otherwise the cells will 
remain stationary. In the Transwell cell migration assay, the cells are influenced by 
chemo-hapotactic attractants, which induce the basic subcellular events of cell migration 
such as membrane protrusions, interaction with extracellular matrix proteins, and actin-
cytoskeletal arrangement, to migrate in a defined direction. This assay measures    
integrin-mediated and growth factor-stimulated migration onto extracellular matrix 
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proteins of isolated cells. CD82 associates with integrins, interferes with integrin 
mediated cell- matrix adhesion, regulates the trafficking of its associated integrins, and 
modulates integrin-initiated signaling events (He et al 2005; Zhang et al 2003). In 
addition, CD82 attenuates growth factor signaling such as EGFR and c-Met signaling 
(Odintsova et al 2000; Odintsova et al 2003; Sridhar and Miranti 2006; Takahashi et al 
2007). At the subcellular level, CD82 inhibits the formation of lamellipodia at the leading 
edge of migrating cells (Liu and Zhang 2006). CD82 has also been implicated to repress 
the trailing edge retraction process of migrating cells by re-organizing the actin 
cytoskeleton, rendering the cells into less motile state, and thereby decreasing the rate of 
cell migration. Collectively, these results suggest that both CD82 WT and CD82 YVAA 
mutant are able to 1) associate with integrins with similar affinities, 2) regulate integrin 
trafficking in a similar manner, and 3) exhibit defects in protrusion and retraction during 
cell migration.  
 
In the wound healing assay, the cells are free to migrate in a random direction but 
typically migrate together in a cell-cell adhesion dependent manner. Although many of 
the biological properties of  Transwell cell migration overlap with the collective cell 
migration observed in wound healing, there are several key differences. In collective cell 
migration, in addition to regulatory factors such as cell-cell adhesion, factors such as 
growth factors, chemokines, and extracellular matrix-cell adhesion directly influences 
migration. For example, collectively migrating cells also 1) interact with each other 
thereby maintaining cell-cell contacts and junctions, 2) coordinate the pushing and 
pulling forces necessary for the maintenance of cell-cell junctions and continuity of cell 
migration, and 3) have the potential to provide each individual cell with spatial input as 
they occupy discrete places and sense the gradients of soluble factors and matrices in the 
environment differently (Friedl and Gilmour 2009; Gaggioli et al 2007; Rørth  et al 
2011).  
 
Compared to the motility of CD82 WT, the increased collective cell migration 
observed in the CD82 YVAA mutant is highly likely to be the direct results of fewer 
CD82 and its associated/regulated proteins being 1) recycled back to the plasma 
membrane and/or 2) secreted via exosomes to the extracellular environment. Exosomes 
are secreted by almost all kinds of cells, and their secretion has been associated with 
immune response, virus incorporation, tumorigenesis, and cancer metastasis. In terms of 
cancer metastasis, exosomes primarily mediate the release of a wide variety of proteins, 
lipids, mRNAs, and micro RNAs, which can be uptaken by neighboring cells and can 
therefore transmit pro-metastatic signals (Shen et al 2011). For collective cell migration, 
the exosomal release may cause the secretion of proteins that either are required for or 
promote cell-cell adhesion from the cells and therefore lead to the reduction in collective 
cell migration. Because the mutation of CD82 YXXΦ motif results in less exosomal 
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release of CD82 and probably also its associated proteins such as CD81, more cell-cell 
adhesion proteins needed for collective cell migration may become available in the 
YVAA mutant cells, and consequently the collective cell migration of the mutant is 
elevated compared to the CD82 wild type cells.     
 
Although cells invade through three dimensional (3D) matrix environment in an 
isolated manner, CD82 YVAA mutant no longer exerts the invasion-inhibitory activity as 
CD82 wild type does, in contrast to the effect of this mutant on solitary cell migration. 
The altered cell-cell adhesion in CD82 YVAA mutant, which contributes to the altered 
collective cell migration as described above, is unlikely involved in the loss of     
invasion-inhibitory activity of this mutant. The only difference between Tranwell cell 
migration and invasion assays is that the tumor cells are surrounded by matrices in 
invasion assay instead of diffusible media in the solitary migration assay. Probably, the 
exosomes released from the cells are accumulated in the cell surroundings and serve as a 
tool to communicate between the isolated cells during invasion process. The exosomes 
may play roles in coordinating cell invasive behaviors, and the altered composition in the 
exosomes due to the YVAA mutation may attenuate the invasiveness of CD82.   
 
 
4.7 THE MUTATION OF THE YXXΦ MOTIF IN CD82 ALTERS CELL-CELL 
ADHESION IN TUMOR CELLS 
 
Because the mutation of CD82 YXXΦ motif selectively alters CD82-mediated 
inhibition of collective cell migration, I analyzed the cell-cell adhesive strength of the 
CD82 YVAA transfectant. Cell–cell adhesion is mediated by cell adhesion proteins such 
as cadherins, immunoglobulin superfamily (IgSF) members, and sometimes integrins, all 
of which are directly or indirectly connected to the actin cytoskeleton and/or intermediate 
filament and thereby provide the mechanical strength at cell-cell contacts (Friedl and 
Gilmour 2009). It has been previously shown that the over-expression of CD82 leads to 
an increase in cell-cell adhesion and a decrease in cell migration (Abe et al 2008; Jackson 
et al 2000; Liu et al 2003; Shibagaki et al 1999). Indeed, I found that the total cell-cell 
adhesion was enhanced upon CD82 expression in Du145 cells. However, in our study, 
the total cell-cell adhesion was reduced upon CD82 expression in PC3 cells. In addition, I 
observed that the mutation of the YXXΦ motif of CD82 leads to an increase in total cell-
cell adhesion in the CD82 YVAA transfectants compared to the CD82 WT transfectants 
in both PC3 and Du145 cells.  
 
The study from Abe et al suggested that CD82-mediated enhancement of cell-cell 
adhesion was calcium-dependent and CD82 upregulated cell-cell adhesion by stabilizing 
the E-cadherin-β-catenin complex (Abe et al 2008). I further analyzed the effect of the 
mutation of the YXXΦ motif on cell-cell adhesion in the absence of calcium. The 
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removal of calcium reduced the cell-cell adhesiveness of the CD82 YVAA mutant to the 
levels of MOCK and CD82WT transfectants in PC3 cells. The removal of calcium had 
minimal effect on the cell-cell adhesion in CD82 WT and MOCK cells. Thus, the 
increase in the total cell-cell adhesion, observed in PC3-CD82 YVAA transfectant, 
appear to be calcium-mediated. But this conclusion may not apply Du145 cells because 
Du145-CD82 YVAA transfectant still exhibited the elevated cell-cell adhesiveness in the 
absence of calcium, nevertheless, the YVAA mutation apparently upregulates cell-cell 
adhesion in some cell types. 
 
The altered cell-cell adhesion may result from the alteration in the expression 
levels or function of cell-cell adhesion molecules or structural integrity of cell-cell 
junctions. To further characterize the cell-cell adhesive/adhesion properties of these 
transfectants, I performed TEM analysis on the transfectant cells that reached confluence 
and formed well-developed cell-cell contacts. I discovered that the YXXΦ motif mutation 
of CD82 led to increases in the number, length, and density of the cell-cell junctions, in 
the PC3-CD82 YVAA transfectant cells compared to the PC3-CD82 WT transfectant 
cells. There was no difference between the MOCK and CD82 YVAA transfectants. This 
morphological change is consistent with the results from cell-cell adhesion assay in PC3 
cells described above.   
 
Invasive tumor cells express cell–cell adhesion molecules including E-, N-, and 
desmosomal cadherins, tight junction proteins, and gap junction proteins. Based on the 
morphological characteristics of these cell-cell junctional structures, I predict that they 
are desmosomes or desmosome-like junctions. The desmosomes are calcium-mediated 
junctional structures. Desmosomal cadherins are the cell-cell adhesion molecules 
responsible for firmly binding neighboring cells together and resisting shear forces and 
mechanical insults. Thus, the electron microscopic observations support the conclusion 
that the mutation of CD82 sorting motif selectively or mainly upregulates calcium-
dependent cell-cell adhesion in PC3 cells. Meanwhile, this electron microscopic result 
does not exclude the changes in other cell-cell adhesion mechanisms that do not form 
cell-cell junctional structures upon the YVAA mutation.    
 
To determine whether the altered cell-cell adhesion caused by the changes in the 
expression levels of cell-cell adhesion molecules, I also analyzed the cell surface 
expression of the most abundant, widely expressed, and well-studied cadherin, E-
cadherin. Abe et al has previously shown that the increase in E-cadherin-mediated      
cell-cell adhesion caused by CD82 overexpression is a direct result of the physical 
association between CD82-E-cadherin and that this association strengthens the               
E-cadherin-mediated intercellular adhesion (Abe et al 2008). Deregulation of E-cadherin 
mediated cell-cell adhesion is associated with increased cancer metastasis and is therefore 
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considered as a tumor metastasis suppressor (Strumane et al 2004). However, I did not 
find significant differences in the cell surface expression levels of E-cadherin between 
any of the transfectants in both PC3 and Du145 cells (data not shown).  
 
Typically, the increased cell-cell adhesion in epithelial cells, with the exception of 
collective cell migration such as wound healing, results in the decrease in cell migration. 
The increased surface expression of cell-cell adhesion proteins usually leads to enhanced 
cell-cell adhesion. Interestingly, I found that the cell surface expression of IgSF cell-cell 
adhesion proteins such as I-CAM and EpCAM are upregulated upon the mutation of the 
YXXΦ motif of CD82 in PC3 cells. Both I-CAM and EpCAM are associated with 
increased cancer metastasis (Brooks et al 2008; Gostner et al 2011; Hayes and Seigel 
2009; Koprowski et al 1979; Lin et al 2006; Osta et al 2004; Trzpis et al 2007; Wang et al 
2006;). EpCAM is expressed on prostate cancer cells and its expression is upregulated in 
the absence of CD82 expression (Mohan et al 2007; Poczatek et al 1999). IgSF proteins 
mediate calcium-independent cell-cell adhesion. The calcium-independent cell-cell 
adhesion was indeed upregulated in the Du145 transfectant but remained unaltered in the 
PC3 transfectant upon the YVAA mutation in CD82. Thus, the molecules responsible for 
the YVAA mutation-induced increase of cell-cell adhesion still remain to be determined. 
Nevertheless,  the altered cell-cell adhesion upon YVAA mutation supports the notion 
that proper trafficking of CD82 to i) the plasma membrane via recycling endosomes and 
ii) the extracellular environment via exosomes are critical steps in the maintenance of 
CD82-mediated suppression of cell motility and likely tumor metastasis as well.  
 
 
4.8 CONCLUSION 
 
Taken together, this data suggests that the YXXΦ motif of CD82 is not important 
for the regulation of internalization but that it is important for recycling and exosomal 
release. Functionally, this motif is important for the maintenance of CD82 suppressive 
regulation of collective cell migration and invasion. I predict that the mutation of the 
YXXΦ motif causes CD82 to use a different intracellular trafficking route, and therefore 
CD82 YVAA mutant exhibits different rates and/or courses in recycling, lysosomal 
targeting, and exosomal release from CD82 WT. An alteration in the intracellular 
trafficking indeed leads to the changes in the functions related to cell motility. For 
example, it can be explained that, due to an accumulation of CD82 YVAA mutant 
proteins within the cells, fewer CD82 YVAA mutant proteins are dynamically presented 
at the cell surface. It appears that such dynamic presentation of CD82 to the cell surface 
during cell movement is important for the motility-inhibitory activity of CD82.    
 
CD82 regulates cell-cell adhesion in both calcium dependent and independent 
manners. With less and/or slower return of CD82 proteins back to the cell surface in the 
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YVAA transfectant cells, metastasis-promoting cell adhesion molecules such as EpCAM,  
which is down-regulated by CD82 WT expression, are now capable of functioning. 
Similarly, more calcium-dependent cell-cell adhesion proteins become functional in 
CD82 YVAA transfectant cells, leading to the increase in cell-cell adhesion. 
Consequently, there is an increase in collective cell migration. This study has 1) shed 
invaluable insight on the mechanism of CD82-mediated inhibition of tumor cell 
migration and invasion, 2) revealed an unexpected, function of the YXXΦ motif, i.e., 
exosomal release, and 3) has further strengthened the notion that intracellular trafficking 
regulates transmembrane protein function.  
  
 
4.9 FUTURE COURSE 
 
It can also be hypothesized that, due to the  accumulation of CD82 YVAA mutant 
proteins within the cells the CD82 YVAA mutant proteins cannot be dynamically  
presented to the cell periphery or surface, supported by the results from recycling and 
exosome release, to elicit the suppressive function  in cell movement. Further 
investigation of the functional importance of exosomes in CD82-mediated inhibition of 
cell migration is needed. The first question that remains to be addresses is whether or not 
the use of purified isolated exosomes from the CD82 WT transfectant is sufficient to 
inhibit cell migration in the MOCK and CD82 YVAA mutant transfectants. The second 
issue that needs to be addressed is whether there is an alteration in the receptors, proteins, 
mRNAs or microRNAs released in the transfectatns. The last question that needs to be 
addressed is whether a mutation of Rab 11 GTPase, a mediator of CD82 recycling, will 
render CD82 WT non-functional.  Answers to these remaining questions will provide 
much needed insight into the mechanistic view of CD82 function, Rab 11 function in 
recycling and exosome secretion, and the influence of exosomal release on neighboring 
cell behaviors. 
 
Of note, I also observed the expressions of cell adhesion and cell surface proteins 
such as CD44, CD24, integrin α2, CD146 are altered upon the CD82 expressions in PC3 
and Du145 cells. Some of these proteins such as CD44, CD24, and integrin α2 are the 
markers of tumor initiating cells or cancer stem cells. It raised an interesting question: 
whether CD82 suppressing tumor progression and metastasis by reducing tumor initiating 
cells or changing the adhesion and migration abilities of tumor initiating cells. This 
remains to be determined in future studies.      
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